[
{"id":"1","list":"Calendar Movers","symbol": "ATNM","name": "Actinium Pharmaceuti","price": 1.44,"dollarChange": 0.03,"percentChange": 1.41,"time":4.0,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/ATNM-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/ATNM-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/ATNM-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/ATNM-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/ATNM-1yr.php","open": 1.4,"high": 1.46,"low":1.4,"volume": 491039,"avgVol": 838656.270833,"sharesShort": 1927163,"shortPercent": 3.465968,"marketCap": 78603422,"float": 55602448,"headlines":{ "data": [ { "title": "Actinium Pharmaceuticals to Present at 29th Annual ROTH Conference", "publication_date": "2017-03-07 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-present-29th-annual-120000510.html", "summary": "[GlobeNewswire] - NEW YORK, March 07, 2017-- Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that Sandesh ..." }, { "title": "7:05 am Actinum Pharma receives a notice of allowance from the United States Patent and Trademark Office for a patent Related to Actimab-A, Actimab-M and the Co's technology platform", "publication_date": "2017-02-28 12:05:00 +0000", "url": "http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#atnm", "summary": "7:05 am Actinum Pharma receives a notice of allowance from the United States Patent and Trademark Office for a patent Related to Actimab-A, Actimab-M and the Co's technology platform" }, { "title": "Actinium Announces Expansion of Intellectual Property Portfolio with Notice of Allowance for U.S. Patent Related to Actimab-A, Actimab-M and the Company’s Technology Platform", "publication_date": "2017-02-28 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-announces-expansion-intellectual-property-120000490.html", "summary": "[GlobeNewswire] - Allowed patent application claims methods for generating radioimmunoconjugates linked to Actinium-225 Patent expected to expire in July 2030 NEW YORK, Feb. 28, 2017-- Actinium Pharmaceuticals, Inc., a ..." }, { "title": "Actinium Pharmaceuticals Announces Active Presence at the BMT Tandem Meetings", "publication_date": "2017-02-23 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-announces-active-presence-120000397.html", "summary": "[GlobeNewswire] - ORLANDO, Fla., Feb. 23, 2017-- Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that ..." }, { "title": "Actinium Pharmaceuticals Announces Hiring of Steven Price to Position of Vice President, Clinical and Commercial Strategy", "publication_date": "2017-02-21 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-announces-hiring-steven-120000373.html", "summary": "[GlobeNewswire] - -Industry veteran to lead development of optimized programs for Iomab-B including initiatives targeted at patients, physicians and payors designed to support clinical development and pre-commercialization ..." }, { "title": "Actinium Pharmaceuticals to Attend the BMT Tandem Meetings, the Combined Annual Meetings of Two Leading Transplant Organizations", "publication_date": "2017-02-14 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-attend-bmt-tandem-120000986.html", "summary": "[GlobeNewswire] - -Members of Actinium’ s executive and clinical development teams to participate in conference activities and extend the visibility of the Company’ s Iomab-B drug candidate to the bone marrow transplant ..." }, { "title": "Actinium Pharmaceuticals to Present at Source Capital Group’s 2017 Disruptive Growth & Healthcare Conference", "publication_date": "2017-02-13 21:15:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-present-source-capital-211500432.html", "summary": "[GlobeNewswire] - NEW YORK, Feb. 13, 2017-- Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that Sandesh ..." }, { "title": "Actinium Pharmaceuticals’ Company Presentation at BIO CEO & Investor Conference to Provide Highlights of Recently Announced Actimab-M Trial in Multiple Myeloma", "publication_date": "2017-02-13 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-company-presentation-bio-120000628.html", "summary": "[GlobeNewswire] - NEW YORK, Feb. 13, 2017-- Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that Sandesh ..." }, { "title": "Actinium Pharmaceuticals To Participate In BIO Investor Conference At 10:00 AM", "publication_date": "2017-02-13 09:00:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pffl9SBiLVw/actinium-pharmaceuticals-to-participate-in-bio-investor-conference-at-1000-am-20170213-00679", "summary": "Actinium Pharmaceuticals To Participate In BIO Investor Conference At 10:00 AM" }, { "title": "Actinium Pharmaceuticals (ATNM) has Considerable Potential in 2017", "publication_date": "2017-02-10 18:16:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-atnm-considerable-potential-181600035.html", "summary": "[Accesswire] - ATNM is Starting New Trials and Will Have Results from Ongoing Phase 3 Trial in 2018 DEERFIELD BEACH, FL / ACCESSWIRE / February 10, 2017 / Actinium Pharmaceuticals Inc. (NYSE MKT: ATNM) concluded 2016 ..." }, { "title": "Actinium Pharmaceuticals to Present at BIO CEO & Investor Conference", "publication_date": "2017-02-09 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-present-bio-ceo-120000402.html", "summary": "[GlobeNewswire] - NEW YORK, Feb. 09, 2017-- Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that Sandesh ..." }, { "title": "Actinium Pharmaceuticals Is Better Than Celator", "publication_date": "2017-02-07 21:45:06 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-better-celator-214506953.html", "summary": "Actinium Pharmaceuticals Is Better Than Celator" }, { "title": "Health Care Sector Update for 02/07/2017: ADHD,ARWR,ATNM", "publication_date": "2017-02-07 21:17:47 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/veQwrYq-oGs/health-care-sector-update-for-02072017-adhdarwratnm-cm744496", "summary": "Top Health Care StocksTop Health Care Stocks JNJ 0 01 JNJ 0 01 PFE 0 53 PFE 0 53 MRK 1 06 MRK 1 06 ABT 1 28 ABT 1 28 AMGN 0 08 AMGN 0 08 Health care stocks were slightly lower this afternoon with the NYSE Health Care Index edging about 0 1 lower while shares of health" }, { "title": "Health Care Sector Update for 02/07/2017: ARWR,AVXL,ATNM", "publication_date": "2017-02-07 18:57:25 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yi_jCg9_55w/health-care-sector-update-for-02072017-arwravxlatnm-cm744411", "summary": "Top Health Care StocksTop Health Care Stocks JNJ 0 04 JNJ 0 04 PFE 0 39 PFE 0 39 MRK 0 81 MRK 0 81 ABT 0 94 ABT 0 94 AMGN 0 25 AMGN 0 25 Health care stocks were little changed Tuesday afternoon with the NYSE Health Care Index edging less than 0 1 lower while shares of health" }, { "title": "Actinium Pharmaceuticals Announces Pipeline Expansion with Initiation of Clinical Trial of Actimab-M in Multiple Myeloma", "publication_date": "2017-02-07 13:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-announces-pipeline-expansion-130000946.html", "summary": "[GlobeNewswire] - -Phase 1 trial will evaluate Actimab-M in treating patients with multiple myeloma who are unresponsive to currently available therapies. -Clinical trial initiated at Texas Oncology- Baylor Charles A. Sammons ..." }, { "title": "Key Catalyst That Could Send Biotechs Soaring in 2017: Today's Reports on MYOS RENS Technology and Actinium Pharmaceuticals", "publication_date": "2017-02-06 14:30:00 +0000", "url": "http://finance.yahoo.com/news/key-catalyst-could-send-biotechs-143000561.html", "summary": "[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 6, 2017 / The Biotech Industry has experienced some steep losses in recent years, but has begun to show some signs of stabilization in 2017. The Industry was home to ..." }, { "title": "Actinium’s Chief Medical Officer, Dr. Mark Berger, to Present Talk Titled, Iomab-B: Radiolabeled CD45 at the 3rd Annual Expert Forum on Acute Leukemias and Myeloproliferative Neoplasms", "publication_date": "2017-01-24 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-chief-medical-officer-dr-120000461.html", "summary": "[GlobeNewswire] - Berger’ s presentation included in session on Immunotherapy and Bispecific Inhibitors in Acute Leukemia. -Two day event will be attended by transplant physicians and hematologists from leading medical ..." }, { "title": "Actinium Announces Participation in Three Upcoming Hematology Events", "publication_date": "2017-01-20 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-announces-participation-three-upcoming-120000884.html", "summary": "[GlobeNewswire] - Representatives from Actinium will attend to promote awareness among attending physicians and health professionals on Iomab-B and the SIERRA trial NEW YORK, Jan. 20, 2017-- Actinium Pharmaceuticals, Inc., ..." }, { "title": "Actinium Strengthens Executive Team and Enhances Clinical Development Capabilities with the Appointment of Dr. Mark Berger as Chief Medical Officer", "publication_date": "2017-01-18 13:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-strengthens-executive-team-enhances-130000378.html", "summary": "[GlobeNewswire] - Berger brings 20 years of drug development experience highlighted by the FDA approvals of Mylotarg ® for acute myeloid leukemia, the only drug approved in AML in several decades, and Tykerb ® for breast ..." }, { "title": "Actinium Pharma. To Present At Biotech Showcase Conference; Webcast At 5:00 PM", "publication_date": "2017-01-10 15:01:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ngoBKEtELSg/actinium-pharma-to-present-at-biotech-showcase-conference-webcast-at-500-pm-20170110-00871", "summary": "Actinium Pharma. To Present At Biotech Showcase Conference; Webcast At 5:00 PM" }, { "title": "Actinium Pharmaceuticals to Present at 9th Annual Biotech Showcase™ 2017 Conference", "publication_date": "2017-01-10 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-present-9th-annual-120000584.html", "summary": "[GlobeNewswire] - NEW YORK, Jan. 10, 2017-- Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that Sandesh ..." }, { "title": "The Life Sciences Report Announces 19 Companies Selected for the 2017 Small-Cap Biotech Watchlist", "publication_date": "2017-01-04 14:00:00 +0000", "url": "http://finance.yahoo.com/news/life-sciences-report-announces-19-140000438.html", "summary": "[Marketwired] - Now in its fifth year, the 2017 Life Sciences Report Biotech Watchlist includes nineteen small-cap biotech companies selected by top analysts in the field, and will be presented at the Biotech Showcase ..." }, { "title": "Actinium Pharmaceuticals to Present at 9th Annual Biotech Showcase™ 2017 Conference", "publication_date": "2017-01-04 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-present-9th-annual-120000444.html", "summary": "[GlobeNewswire] - NEW YORK, Jan. 04, 2017-- Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that Sandesh ..." }, { "title": "Tuesday 1/3 Insider Buying Report: OPK, ATNM", "publication_date": "2017-01-03 16:58:38 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c_6rKBsIQ7E/tuesday-13-insider-buying-report-opk-atnm-cm728666", "summary": "Bargain hunters are wise to pay careful attention to insider buying because although there are many various reasons for an insider to sell a stock presumably the only reason they would use their hard earned dollars to make a purchase is that they expect to make money Today we look at" }, { "title": "ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders", "publication_date": "2016-12-22 13:05:34 +0000", "url": "http://biz.yahoo.com/e/161222/atnm8-k.html", "summary": "ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders" }, { "title": "Actinium Pharmaceuticals Appoints Jeannine Larrieux, Ph.D. as Director of Analytical Development to Support BLA and IND Enabling Analytical Studies for Current and Future Clinical Programs", "publication_date": "2016-12-19 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-appoints-jeannine-larrieux-120000069.html", "summary": "[GlobeNewswire] - Larrieux brings significant experience managing analytical development quality control of immunotherapies to treat cancer and small molecule therapies at pharmaceutical and biotechnology organizations. ..." }, { "title": "ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a", "publication_date": "2016-12-14 22:14:37 +0000", "url": "http://biz.yahoo.com/e/161214/atnm8-k.html", "summary": "ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a" }, { "title": "Actinium Pharmaceuticals Announces Submission of EU Orphan Designation Application for Actimab-A", "publication_date": "2016-12-13 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-announces-submission-eu-120000310.html", "summary": "[GlobeNewswire] - -Actimab-A has received Orphan Drug Designation in the U.S.. -Orphan Designation in the EU can result in regulatory assistance, reduced fees and 10 years of market exclusivity. NEW YORK, Dec. 13, 2016-- ..." }, { "title": "Actinium to Sponsor Upcoming Blood & Marrow Transplant Information Network Webinar Focused on Stem Cell Transplants for Patients with AML", "publication_date": "2016-12-12 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-sponsor-upcoming-blood-marrow-120000640.html", "summary": "[GlobeNewswire] - Patient focused webinar titled“ Stem Cell Transplants for Acute Myeloid Leukemia: What you Need to Know” Webinar to be led by transplant expert, Dr. Patrick Stiff, Director of the Cardinal Bernardin Cancer ..." }, { "title": "Actinium Pharmaceuticals, Inc. :ATNM-US: Earnings Analysis: Q3, 2016 By the Numbers : December 6, 2016", "publication_date": "2016-12-06 15:10:51 +0000", "url": "http://www.capitalcube.com/blog/index.php/actinium-pharmaceuticals-inc-atnm-us-earnings-analysis-q3-2016-by-the-numbers-december-6-2016/", "summary": "Actinium Pharmaceuticals, Inc. :ATNM-US: Earnings Analysis: Q3, 2016 By the Numbers : December 6, 2016" }, { "title": "Actinium Pharmaceuticals To Participate In LD Micro Main Event At 2:30 PM ET", "publication_date": "2016-12-06 13:30:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7cuOxo5BDOE/actinium-pharmaceuticals-to-participate-in-ld-micro-main-event-at-230-pm-et-20161206-00909", "summary": "Actinium Pharmaceuticals To Participate In LD Micro Main Event At 2:30 PM ET" }, { "title": "Actinium Highlights Results from Phase 1 Clinical Trial of Actimab-A at 58th American Society of Hematology Annual Meeting", "publication_date": "2016-12-06 02:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-highlights-results-phase-1-020000522.html", "summary": "[GlobeNewswire] - Analysis of 2 Actimab-A Phase 1 clinical trials show that 42% of patients with low peripheral blast burden responded to Actimab-A while no patients with high PB burden responded to Actimab-A Key threshold ..." }, { "title": "Actinium Further Strengthens Clinical Development Team with Senior Hire to Support Later-Stage Clinical Trials", "publication_date": "2016-11-29 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-further-strengthens-clinical-development-120000543.html", "summary": "[GlobeNewswire] - NEW YORK, Nov. 29, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today the ..." }, { "title": "Actinium Issues Letter to Shareholders Highlighting 2016 Accomplishments and Anticipated Milestones for 2017", "publication_date": "2016-11-22 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-issues-letter-shareholders-highlighting-120000733.html", "summary": "[GlobeNewswire] - NEW YORK, Nov. 22, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that it has ..." }, { "title": "Actinium Pharmaceuticals to Present at LD Micro Main Event Investor Conference", "publication_date": "2016-11-21 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-present-ld-micro-120000548.html", "summary": "[GlobeNewswire] - NEW YORK, Nov. 21, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today the ..." }, { "title": "Actinium Announces Notice of Allowance for U.S. Patent Related to Actimab-A", "publication_date": "2016-11-14 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-announces-notice-allowance-u-120000066.html", "summary": "[GlobeNewswire] - Allowed patent application claims method for purifying actinium-225. NEW YORK, Nov. 14, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical Company developing innovative targeted payload immunotherapeutics ..." }, { "title": "ACTINIUM PHARMACEUTICALS, INC. Financials", "publication_date": "2016-11-03 17:04:07 +0000", "url": "http://finance.yahoo.com/q/is?s=atnm", "summary": "ACTINIUM PHARMACEUTICALS, INC. Financials" }, { "title": "Actinium Pharmaceuticals Announces Key Hire in Clinical Supply Chain Organization as Company Expands To Accommodate Continued Growth", "publication_date": "2016-10-31 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-announces-key-hire-110000244.html", "summary": "[GlobeNewswire] - -Incoming Industry Veteran to Lead Clinical Supply Chain Operations and Architect the Build Out of the Anticipated Commercial Supply Chain. NEW YORK, Oct. 31, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical ..." }, { "title": "ACTINIUM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report", "publication_date": "2016-10-28 21:04:35 +0000", "url": "http://biz.yahoo.com/e/161028/atnm10-q.html", "summary": "ACTINIUM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report" }, { "title": "Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth", "publication_date": "2016-10-26 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-announces-hires-supply-110000220.html", "summary": "[GlobeNewswire] - -Incoming specialists to focus on Quality Control and Quality Assurance Aspects of Supply Chain. NEW YORK, Oct. 26, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical Company developing innovative ..." }, { "title": "Actinium Pharmaceuticals Initiates Pursuit of Scientific Advice for Iomab-B from the European Medicines Agency", "publication_date": "2016-10-25 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-initiates-pursuit-scientific-110000319.html", "summary": "[GlobeNewswire] - -Company is seeking guidance on development plan of Iomab-B for the EU market. -Actinium’ s small and medium-sized status and orphan designation results in a 100% reduction in fees for scientific advice. ..." }, { "title": "[$$] Clinical Development News, Oct. 17-21", "publication_date": "2016-10-21 22:45:30 +0000", "url": "http://www.wsj.com/articles/clinical-development-news-oct-17-21-1477089923?mod=yahoo_hs", "summary": "[$$] Clinical Development News, Oct. 17-21" }, { "title": "Actinium Announces Acceptance of Actimab-A Data for Poster Presentation at American Society of Hematology Annual Meeting", "publication_date": "2016-10-19 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-announces-acceptance-actimab-data-110000684.html", "summary": "[GlobeNewswire] - NEW YORK, Oct. 19, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that ..." }, { "title": "Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Iomab-B", "publication_date": "2016-10-18 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-granted-orphan-designation-110000752.html", "summary": "[GlobeNewswire] - -Orphan designation is expected to provide increased communication and guidance from regulators and 10- year market exclusivity should marketing authorization be obtained. -Orphan designation for Iomab-B ..." }, { "title": "Actinium Announces Closing of Public Offering of Common Stock", "publication_date": "2016-10-04 20:15:00 +0000", "url": "http://finance.yahoo.com/news/actinium-announces-closing-public-offering-201500689.html", "summary": "[GlobeNewswire] - NEW YORK, Oct. 04, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today the ..." }, { "title": "Why PepsiCo, Philip Morris, Fitbit, and Two Other Stocks Are Making Headlines Today", "publication_date": "2016-09-29 15:34:42 +0000", "url": "http://www.insidermonkey.com/blog/why-pepsico-philip-morris-fitbit-and-two-other-stocks-are-making-headlines-today-477546/", "summary": "Why PepsiCo, Philip Morris, Fitbit, and Two Other Stocks Are Making Headlines Today" }, { "title": "ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosu", "publication_date": "2016-09-29 12:46:38 +0000", "url": "http://biz.yahoo.com/e/160929/atnm8-k.html", "summary": "ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosu" }, { "title": "Actinium Announces Pricing of Public Offering of Common Stock", "publication_date": "2016-09-29 12:16:30 +0000", "url": "http://finance.yahoo.com/news/actinium-announces-pricing-public-offering-121630981.html", "summary": "[GlobeNewswire] - NEW YORK, Sept. 29, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today the ..." }, { "title": "Actinium Announces Proposed Public Offering of Common Stock", "publication_date": "2016-09-28 20:10:00 +0000", "url": "http://finance.yahoo.com/news/actinium-announces-proposed-public-offering-201000500.html", "summary": "[GlobeNewswire] - NEW YORK, Sept. 28, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that ..." }, { "title": "GALT In A Fix, SHPG Ends Biosimilar Deals, KTOV Moves Closer To File KIT-302 NDA", "publication_date": "2016-09-28 02:05:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SBCeLZoMMiY/galt-in-a-fix-shpg-ends-biosimilar-deals-ktov-moves-closer-to-file-kit302-nda-20160928-00040", "summary": "GALT In A Fix, SHPG Ends Biosimilar Deals, KTOV Moves Closer To File KIT-302 NDA" }, { "title": "Actinium Pharma To Present At Ladenburg Thalmann Conference; Webcast At 1:00 PM", "publication_date": "2016-09-27 12:00:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VM3vX6H2Caw/actinium-pharma-to-present-at-ladenburg-thalmann-conference-webcast-at-100-pm-20160927-00341", "summary": "Actinium Pharma To Present At Ladenburg Thalmann Conference; Webcast At 1:00 PM" }, { "title": "Actinium Announces Initiation of Phase 2 Clinical Trial of Actimab-A in Patients Newly Diagnosed with Acute Myeloid Leukemia Over Age 60", "publication_date": "2016-09-27 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-announces-initiation-phase-2-110000268.html", "summary": "[GlobeNewswire] - Webinar to be held at 9:00 AM ET to highlight Actimab-A Phase 2 clinical trial and protocol revisions agreed to by the FDA Protocol revisions agreed to by the FDA include the use of peripheral blast burden ..." }, { "title": "Actinium Pharmaceuticals to Sponsor and Participate in Be The Match® Walk+Run to Raise Awareness for Bone Marrow Transplant", "publication_date": "2016-09-26 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-sponsor-participate-match-110000520.html", "summary": "[GlobeNewswire] - NEW YORK, Sept. 26, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that ..." }, { "title": "Actinium Pharmaceuticals to Host Webinar to Provide Update on Actimab-A Phase 2 Clinical Trial", "publication_date": "2016-09-21 12:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-host-webinar-actimab-120000716.html", "summary": "[GlobeNewswire] - -Webinar to be Held on Tuesday, September 27, 2016 at 9:00 AM ET. -Webinar to feature Principle Investigator Joseph Jurcic, M.D., Professor of Clinical Medicine and Director of the Hematologic Malignancies ..." }, { "title": "Actinium Pharmaceuticals, Inc. :ATNM-US: Earnings Analysis: Q2, 2016 By the Numbers : September 20, 2016", "publication_date": "2016-09-20 16:19:45 +0000", "url": "http://www.capitalcube.com/blog/index.php/actinium-pharmaceuticals-inc-atnm-us-earnings-analysis-q2-2016-by-the-numbers-september-20-2016/", "summary": "Actinium Pharmaceuticals, Inc. :ATNM-US: Earnings Analysis: Q2, 2016 By the Numbers : September 20, 2016" }, { "title": "Actinium Pharmaceuticals Selects Vector Oncology as its Clinical Research Organization for Actimab-A Phase 2 Trial", "publication_date": "2016-09-20 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-selects-vector-oncology-110000763.html", "summary": "[GlobeNewswire] - NEW YORK, Sept. 20, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that ..." }, { "title": "Actinium Pharmaceuticals to Present at Ladenburg Thalmann 2nd Annual Healthcare Conference", "publication_date": "2016-09-19 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-present-ladenburg-thalmann-110000011.html", "summary": "Actinium Pharmaceuticals to Present at Ladenburg Thalmann 2nd Annual Healthcare Conference" }, { "title": "Actinium Pharmaceuticals Presenting at Rodman & Renshaw 18th Annual Global Investment Conference", "publication_date": "2016-09-13 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-presenting-rodman-renshaw-110000032.html", "summary": "Actinium Pharmaceuticals Presenting at Rodman & Renshaw 18th Annual Global Investment Conference" }, { "title": "Actinium Pharma. To Participate In Biotech Industry Conference At 2:30 PM ET", "publication_date": "2016-09-09 13:30:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wkgowaF0TWI/actinium-pharma-to-participate-in-biotech-industry-conference-at-230-pm-et-20160909-00522", "summary": "Actinium Pharma. To Participate In Biotech Industry Conference At 2:30 PM ET" }, { "title": "Actinium Pharmaceuticals Presenting at the BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference", "publication_date": "2016-09-09 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-presenting-biocentury-23rd-110000110.html", "summary": "[GlobeNewswire] - Company Presentation Scheduled for Friday, September 9, 2016 at 2:30 PM ET Presentation can be viewed via webcast NEW YORK, Sept. 09, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical company ..." }, { "title": "Actinium Enhances Capabilities with Hiring of Industry and Clinical Research Veterans to its Product Development and Clinical Development Teams", "publication_date": "2016-09-07 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-enhances-capabilities-hiring-industry-110000927.html", "summary": "[GlobeNewswire] - NEW YORK, Sept. 07, 2016-- Actinium Pharmaceuticals, Inc., a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that ..." }, { "title": "Actinium to Present at Rodman & Renshaw 18th Annual Global Investment Conference", "publication_date": "2016-08-30 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-present-rodman-renshaw-18th-110000221.html", "summary": "[Marketwired] - Actinium Pharmaceuticals, Inc. Company to Present on Tuesday, September 13, 2016 at 10:25 AM ETManagement to Participate in 1-on-1 Investor MeetingsActinium Pharmaceuticals, Inc. , a..." }, { "title": "These 5 Stocks Are Breaking Out", "publication_date": "2016-08-26 16:00:00 +0000", "url": "https://www.thestreet.com/story/13686807/1/these-5-stocks-are-breaking-out.html?puc=yahoo&cm_ven=YAHOO", "summary": "These 5 Stocks Are Breaking Out" }, { "title": "Coverage initiated on Actinum Pharma by ROTH Capital", "publication_date": "2016-08-25 12:20:04 +0000", "url": "http://finance.yahoo.com/q/ud?s=ATNM", "summary": "Coverage initiated on Actinum Pharma by ROTH Capital" }, { "title": "Actinium Pharmaceuticals to Present at the BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference", "publication_date": "2016-08-23 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-present-biocentury-23rd-110000935.html", "summary": "[Marketwired] - Company Presentation Scheduled for Friday, September 9, 2016 at 2:30 PM ETManagement to Participate in 1-on-1 Investor MeetingsActinium Pharmaceuticals, Inc. , a biopharmaceutical company developing......" }, { "title": "The Life Sciences Report Examines Actinium's Radioimmunotherapies", "publication_date": "2016-08-18 13:00:00 +0000", "url": "http://finance.yahoo.com/news/life-sciences-report-examines-actiniums-130000928.html", "summary": "[Marketwired] - Radioimmunotherapy is experiencing a renaissance, and Actinium Pharmaceuticals Inc. is in position to benefit, according to company executive chairman Sandesh Seth. With two assets targeting treatment ..." }, { "title": "Actinium Pharmaceuticals Granted SME Status by the European Medicines Agency; Reiterates Focus on EU Market", "publication_date": "2016-08-09 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-granted-sme-status-110000805.html", "summary": "Actinium Pharmaceuticals Granted SME Status by the European Medicines Agency; Reiterates Focus on EU Market" }, { "title": "ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2016-08-04 12:01:34 +0000", "url": "http://biz.yahoo.com/e/160804/atnm8-k.html", "summary": "ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "Actinium Pharmaceuticals Issues Mid-Year Letter to Shareholders Providing Update on Company Progress and Anticipated Milestones", "publication_date": "2016-08-04 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-issues-mid-letter-110000812.html", "summary": "[Marketwired] - Iomab-B Pivotal Phase 3 Trial Initiation Signals Transformation of Company Profile to Later-Stage Development Actimab-A Progressing into Phase 2 Clinical Trial with Impetus from Phase I Results and Peripheral ..." }, { "title": "Actinium Pharma Highlights Its Recent Progress And Corporate Milestones", "publication_date": "2016-08-04 07:44:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eKG7tfRc-Q8/actinium-pharma-highlights-its-recent-progress-and-corporate-milestones-20160804-00445", "summary": "Actinium Pharma Highlights Its Recent Progress And Corporate Milestones" }, { "title": "ACTINIUM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report", "publication_date": "2016-07-29 20:48:43 +0000", "url": "http://biz.yahoo.com/e/160729/atnm10-q.html", "summary": "ACTINIUM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report" }, { "title": "Actinium: Another Promising Name in the AML Space", "publication_date": "2016-07-27 16:11:00 +0000", "url": "http://finance.yahoo.com/news/actinium-another-promising-name-aml-161100369.html", "summary": "[Accesswire] - DEERFIELD BEACH, FL / ACCESSWIRE / July 27, 2016 / While this has been a mixed year for the biotechnology sector, there have been some clear winners. Celator Pharmaceuticals Inc. (NASDAQ: CPXX) is one ..." }, { "title": "Actinium Pharmaceuticals: Another Promising Name In The AML Space", "publication_date": "2016-07-27 15:49:09 +0000", "url": "http://ir.baystreet.ca/article.aspx?id=255&1469634549", "summary": "Actinium Pharmaceuticals: Another Promising Name In The AML Space" }, { "title": "Actinium Pharmaceuticals Highlights Successful Investigator Meeting for Pivotal Phase 3 Iomab-B SIERRA Trial", "publication_date": "2016-07-20 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-highlights-successful-investigator-110000093.html", "summary": "[Marketwired] - Actinium Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that the Company conducted ..." }, { "title": "Actinum Pharma Conducts Investigator Meeting For Phase 3 Iomab-B Sierra Trial", "publication_date": "2016-07-20 07:14:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yFfOEsAZeV0/actinum-pharma-conducts-investigator-meeting-for-phase-3-iomabb-sierra-trial-20160720-00245", "summary": "Actinum Pharma Conducts Investigator Meeting For Phase 3 Iomab-B Sierra Trial" }, { "title": "Actinium Receives Assignment of Intellectual Property From Memorial Sloan Kettering Cancer Center Specific to Actinium's APIT Platform and the Use of Actinium-225", "publication_date": "2016-07-12 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-receives-assignment-intellectual-property-110000366.html", "summary": "[Marketwired] - Actinium Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that the Company has been......" }, { "title": "Actinium Pharmaceuticals to Sponsor Investigator Meeting for Pivotal Phase 3 SIERRA Trial for Iomab-B", "publication_date": "2016-07-06 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-sponsor-investigator-meeting-110000286.html", "summary": "[Marketwired] - Meeting to be Attended by Bone Marrow Transplant Physicians, Care Providers and Clinical Research Coordinators from Leading Transplant CentersActinium Scientific Advisory Board Members and Management to ..." }, { "title": "Actinium Pharmaceuticals Initiates Pivotal Phase 3 SIERRA Trial", "publication_date": "2016-06-29 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-initiates-pivotal-phase-110000083.html", "summary": "[Marketwired] - Iomab-B Uniquely Positioned as the Only Investigational Therapy Intended to be an Induction and Conditioning Agent Prior to a Bone Marrow Transplant in its Target Patient PopulationSIERRA Phase 3 Trial ..." }, { "title": "Actinium Pharma Initiates Pivotal Phase 3 SIERRA Trial - Quick Facts", "publication_date": "2016-06-29 07:12:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8Eklquk_cg4/actinium-pharma-initiates-pivotal-phase-3-sierra-trial--quick-facts-20160629-00183", "summary": "Actinium Pharma Initiates Pivotal Phase 3 SIERRA Trial - Quick Facts" }, { "title": "Actinium Pharma Initiates Pivotal Phase 3 SIERRA Trial - Quick Facts", "publication_date": "2016-06-29 07:12:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GWtKFQMmMOk/actinium-pharma-initiates-pivotal-phase-3-sierra-trial--quick-facts-20160629-00184", "summary": "Actinium Pharma Initiates Pivotal Phase 3 SIERRA Trial - Quick Facts" }, { "title": "Actinium Sponsored Acute Myeloid Leukemia (AML) Awareness Month to Feature Webinar Focused on Transplantation as a Treatment Option for Blood Cancers", "publication_date": "2016-06-28 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-sponsored-acute-myeloid-leukemia-110000170.html", "summary": "[Marketwired] - Webinar to be held on Tuesday, June 28, 2016 from 1:30 - 2:30 pm ETJohn Pagel, M.D., Ph.D., Actinium Advisory Board Member, and Panel of Experts to Discuss Bone Marrow Transplant Actinium Pharmaceuticals, ..." }, { "title": "Actinium Sponsored Acute Myeloid Leukemia (AML) Awareness Month Continues With Medical Update Webinar", "publication_date": "2016-06-15 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-sponsored-acute-myeloid-leukemia-110000097.html", "summary": "[Marketwired] - Actinium Pharmaceuticals, Inc. Webinar to Be Held on Friday, June 17, 2016 Featuring Thought Leaders in the Field of AML John Pagel, M.D., Ph.D., Actinium Advisory Board Member, to Discuss Bone Marrow ..." }, { "title": "Actinium Announces Strong Presence at Society of Nuclear Medicine and Molecular Imaging Annual Meeting", "publication_date": "2016-06-09 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-announces-strong-presence-society-110000586.html", "summary": "[Marketwired] - Company will host an educational event on Monday, June 13th focused on the upcoming Iomab-B Phase 3 SIERRA trial and alpha particle radioimmunotherapyDr. Joseph Jurcic, Director of Hematologic Malignancies ..." }, { "title": "Actinium Announces Upcoming Iomab-B Phase 3 SIERRA Trial", "publication_date": "2016-06-09 07:11:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lGWsX4TUSjo/actinium-announces-upcoming-iomabb-phase-3-sierra-trial-20160609-00185", "summary": "Actinium Announces Upcoming Iomab-B Phase 3 SIERRA Trial" }, { "title": "Actinium Announces Upcoming Iomab-B Phase 3 SIERRA Trial", "publication_date": "2016-06-09 07:11:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qOxKAPRRDOM/actinium-announces-upcoming-iomabb-phase-3-sierra-trial-20160609-00184", "summary": "Actinium Announces Upcoming Iomab-B Phase 3 SIERRA Trial" }, { "title": "Actinium Pharmaceuticals, Inc. :ATNM-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016", "publication_date": "2016-06-08 22:08:31 +0000", "url": "http://www.capitalcube.com/blog/index.php/actinium-pharmaceuticals-inc-atnm-us-earnings-analysis-q1-2016-by-the-numbers-june-8-2016/", "summary": "Actinium Pharmaceuticals, Inc. :ATNM-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016" }, { "title": "Actinium to Present at BIO International Convention to Provide Updates on Actimab-A and Iomab-B Programs", "publication_date": "2016-06-08 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-present-bio-international-convention-110000405.html", "summary": "[Marketwired] - Actinium Pharmaceuticals, Inc. , a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that Sandesh Seth, Executive......" }, { "title": "ARIAD (ARIA) Presents Phase II Study Data on Cancer Drug", "publication_date": "2016-06-07 18:11:20 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X0A03V9Lzww/ariad-aria-presents-phase-ii-study-data-on-cancer-drug-cm631778", "summary": "ARIAD Pharmaceuticals, Inc.ARIA presented updated data from a pivotal phase II study (ALTA) on its most advanced pipeline candidate brigatinib, in patients with ALK+ non small cell lung cancer (NSCLC) who had experienced disease progression on Pfizer Inc.'s PFE" }, { "title": "Actinium Pharmaceuticals Applauds CancerCare(R) for Launching the First Ever Acute Myeloid Leukemia Awareness Month", "publication_date": "2016-06-02 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-applauds-cancercare-r-110000192.html", "summary": "[Marketwired] - Actinium Pharmaceuticals, Inc. , a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of patients with advanced cancers, applauds CancerCare for their......" }, { "title": "Why Galena Biopharma, Whole Foods, Ocean Power Tech, Actinium Pharma & Shopify Spiked Today", "publication_date": "2016-06-01 19:10:41 +0000", "url": "http://www.insidermonkey.com/blog/why-galena-biopharma-whole-foods-ocean-power-tech-actinium-pharma-shopify-spiked-today-457263/", "summary": "Why Galena Biopharma, Whole Foods, Ocean Power Tech, Actinium Pharma & Shopify Spiked Today" }, { "title": "Actinium Pharmaceuticals Announces Positive Safety and Efficacy Results From Phase 1 Actimab-A Trial in Patients With Newly Diagnosed Acute Myeloid Leukemia and Provides Guidance on Plans for Phase 2 Clinical Trial", "publication_date": "2016-06-01 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-pharmaceuticals-announces-positive-safety-110000269.html", "summary": "[Marketwired] - Analysis of clinical trials from Actimab-A portion of Actinium's HuM195-Alpha program show low peripheral blast burden results in improved patient responses Phase 2 trial to begin enrolling patients in ..." }, { "title": "Actinium Announces Positive Results From Phase 1 Actimab-A Trial", "publication_date": "2016-06-01 07:26:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NqsoPDXD8Sk/actinium-announces-positive-results-from-phase-1-actimaba-trial-20160601-00274", "summary": "Actinium Announces Positive Results From Phase 1 Actimab-A Trial" }, { "title": "Actinium Announces Webinar to Discuss Results of the Actimab-A Phase 1 Trial and Key Findings From the HuM195-Alpha Program", "publication_date": "2016-05-18 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-announces-webinar-discuss-results-110000887.html", "summary": "[Marketwired] - Actinium Pharmaceuticals, Inc. , a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of patients with advanced cancers, announced today that the..." }, { "title": "Actinium to Present at BIO International Convention and Provide Updates on Actimab-A and Iomab-B Programs", "publication_date": "2016-05-10 11:00:00 +0000", "url": "http://finance.yahoo.com/news/actinium-present-bio-international-convention-110000434.html", "summary": "Actinium to Present at BIO International Convention and Provide Updates on Actimab-A and Iomab-B Programs" }, { "title": "Should You Buy Actinium Pharmaceuticals (ATNM) Ahead of Earnings?", "publication_date": "2016-03-17 14:53:12 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nh_sLkgPeuE/should-you-buy-actinium-pharmaceuticals-atnm-ahead-of-earnings-cm594421", "summary": "Investors are always looking for stocks that are poised to beat at earnings season and Actinium Pharmaceuticals, Inc. ATNM may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely" }, { "title": "Adobe Systems (ADBE): A Surprise in Q1 Earnings Release?", "publication_date": "2016-03-14 16:45:27 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bHYeaRhfoOw/adobe-systems-adbe-a-surprise-in-q1-earnings-release-cm592754", "summary": "Adobe Systems IncorporatedADBE is slated to report first quarter fiscal 2016 results on Mar 17. Last quarter, the company recorded a positive earnings surprise of 4.44%. Let's see how things are shaping up for this announcement. Factors to Consider" }, { "title": "What's in Store for Catalyst (CPRX) this Earnings Season?", "publication_date": "2016-03-14 16:44:22 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XcnHXolGnbg/whats-in-store-for-catalyst-cprx-this-earnings-season-cm592738", "summary": "Catalyst Pharmaceutical Partners Inc . CPRX is scheduled to report fourth quarter 2015 results after the market closes on Mar 15. Catalyst has had an impressive track record so far. The company beat estimates in three of the last" }, { "title": "Actinium Pharmaceuticals (ATNM) in Focus: Stock Jumps 5.3%", "publication_date": "2016-01-05 17:21:43 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CtKU5lCC4uw/actinium-pharmaceuticals-atnm-in-focus-stock-jumps-53-cm561447", "summary": "Actinium Pharmaceuticals, Inc.ATNM was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session." }, { "title": "Actinium Pharmaceuticals (ATNM) Jumps: Stock Up 7.2%", "publication_date": "2015-12-29 15:20:52 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7f4kT6fBTJU/actinium-pharmaceuticals-atnm-jumps-stock-up-72-cm559416", "summary": "Actinium Pharmaceuticals, Inc.ATNM was a big mover last session, as its shares rose over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday's rally continues" }, { "title": "Thursday Sector Laggards: Biotechnology, Music & Electronics Stores", "publication_date": "2015-03-26 19:05:22 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CtmlcZpfAU0/thursday-sector-laggards-biotechnology-music-electronics-stores-cm459385", "summary": "In trading on Thursday, biotechnology shares were relative laggards, down on the day by about 1.8%. Helping drag down the group were shares of Neuralstem ( CUR ), down about 12.3% and shares of Actinium Pharmaceuticals ( ATNM )" } ], "result_count": 100, "page_size": 250, "current_page": 1, "total_pages": 1, "api_call_credits": 1 }, "chart":[{"values":[ {"x":"1489411800","y":"1.41"},{"x":"1489412100","y":"1.4315"},{"x":"1489412400","y":"1.44"},{"x":"1489412700","y":"1.45"},{"x":"1489413000","y":"1.44"},{"x":"1489413300","y":"1.45"},{"x":"1489413600","y":"1.43"},{"x":"1489413900","y":"1.43"},{"x":"1489414200","y":"1.43"},{"x":"1489414500","y":"1.425"},{"x":"1489414800","y":"1.43"},{"x":"1489415100","y":"1.425"},{"x":"1489415400","y":"1.435"},{"x":"1489415700","y":"1.435"},{"x":"1489416000","y":"1.44"},{"x":"1489416300","y":"1.44"},{"x":"1489416600","y":"1.435"},{"x":"1489416900","y":"1.435"},{"x":"1489417200","y":"1.44"},{"x":"1489417500","y":"1.45"},{"x":"1489417800","y":"1.45"},{"x":"1489418100","y":"1.455"},{"x":"1489418400","y":"1.45"},{"x":"1489418700","y":"1.455"},{"x":"1489419000","y":"1.445"},{"x":"1489419300","y":"1.44"},{"x":"1489419600","y":"1.44"},{"x":"1489419900","y":"1.44"},{"x":"1489420200","y":"1.435"},{"x":"1489420500","y":"1.43"},{"x":"1489420800","y":"1.45"},{"x":"1489421100","y":"1.45"},{"x":"1489421400","y":"1.445"},{"x":"1489421700","y":"1.445"},{"x":"1489422000","y":"1.45"},{"x":"1489422300","y":"1.455"},{"x":"1489422600","y":"1.45"},{"x":"1489422900","y":"1.4506999999999999"},{"x":"1489423200","y":"1.45"},{"x":"1489423800","y":"1.45"},{"x":"1489424100","y":"1.45"},{"x":"1489424400","y":"1.45"},{"x":"1489424700","y":"1.45"},{"x":"1489425000","y":"1.455"},{"x":"1489425300","y":"1.455"},{"x":"1489425600","y":"1.45"},{"x":"1489425900","y":"1.4501"},{"x":"1489426200","y":"1.45"},{"x":"1489426500","y":"1.455"},{"x":"1489426800","y":"1.4506999999999999"},{"x":"1489427100","y":"1.448"},{"x":"1489427400","y":"1.445"},{"x":"1489427700","y":"1.445"},{"x":"1489428000","y":"1.45"},{"x":"1489428300","y":"1.45"},{"x":"1489428600","y":"1.45"},{"x":"1489428900","y":"1.45"},{"x":"1489429200","y":"1.45"},{"x":"1489429500","y":"1.45"},{"x":"1489429800","y":"1.45"},{"x":"1489430100","y":"1.445"},{"x":"1489430400","y":"1.45"},{"x":"1489430700","y":"1.44"},{"x":"1489431000","y":"1.44"},{"x":"1489431300","y":"1.45"},{"x":"1489431600","y":"1.45"},{"x":"1489431900","y":"1.45"},{"x":"1489432200","y":"1.45"},{"x":"1489432500","y":"1.45"},{"x":"1489432800","y":"1.44"},{"x":"1489433100","y":"1.44"},{"x":"1489433400","y":"1.43"},{"x":"1489433700","y":"1.43"},{"x":"1489434000","y":"1.43"},{"x":"1489434300","y":"1.43"},{"x":"1489434600","y":"1.425"},{"x":"1489434900","y":"1.435"},{"x":"1489435200","y":"1.44"} ], "color":"#03a9f4"}]},
{"id":"2","list":"Calendar Movers","symbol": "ESES","name": "Eco-Stim Energy Solu","price": 1.15,"dollarChange": 0.07,"percentChange": 6.49,"time":2.0,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/ESES-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/ESES-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/ESES-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/ESES-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/ESES-1yr.php","open": 1.08,"high": 1.19,"low":1.08,"volume": 195247,"avgVol": 906338.104167,"sharesShort": 439206,"shortPercent": 3.234380,"marketCap": 14271118,"float": 13579296,"headlines":{ "data": [ { "title": "Q4 2016 Eco-Stim Energy Solutions Inc Earnings Release - 06:00 am ET", "publication_date": "2017-03-10 12:07:05 +0000", "url": "http://biz.yahoo.com/research/earncal/20170310.html?t=eses", "summary": "Q4 2016 Eco-Stim Energy Solutions Inc Earnings Release - 06:00 am ET" }, { "title": "Eco-Stim Energy Solutions Reports Fourth Quarter and Full Year 2016 Results; Expanding into US Market While Maintaining Firm Position in Argentina", "publication_date": "2017-03-10 11:00:00 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-reports-110000909.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced its financial and operating results for the quarter and year ended December 31, 2016." }, { "title": "ECO-STIM ENERGY SOLUTIONS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct", "publication_date": "2017-03-09 20:37:05 +0000", "url": "http://biz.yahoo.com/e/170309/eses8-k.html", "summary": "ECO-STIM ENERGY SOLUTIONS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct" }, { "title": "Eco-Stim Energy Solutions Strengthens Management Team Industry Veteran Joins Company", "publication_date": "2017-03-09 11:00:00 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-strengthens-110000069.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. is proud to announce the addition of Barry Ekstrand to its senior management team. Barry will support the company as Senior Vice President of Operations - North America ..." }, { "title": "Energy Sector Update for 03/07/2017: ESES,WFT,AMID", "publication_date": "2017-03-07 18:32:50 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1woLZG0JHZU/energy-sector-update-for-03072017-eseswftamid-cm757392", "summary": "Top Energy StocksTop Energy Stocks XOM 0 49 XOM 0 49 CVX 0 81 CVX 0 81 COP 0 87 COP 0 87 SLB 0 90 SLB 0 90 OXY 0 17 OXY 0 17 Energy stocks were trending lower Tuesday with the NYSE Energy Sector Index sinking about 0 4 while shares of energy companies in the S amp P 500 were" }, { "title": "EcoStim Completes Recapitalization with Fir Tree Partners; Secures $17 million in New Funding Positioning the Company for Growth and a Debt Free Balance Sheet", "publication_date": "2017-03-07 01:00:00 +0000", "url": "http://finance.yahoo.com/news/ecostim-completes-recapitalization-fir-tree-010000710.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that an affiliate of Fir Tree Partners entered into a transaction with an affiliate of Albright Capital Management LLC pursuant to which FTP has purchased ..." }, { "title": "Eco-Stim Energy Solutions Announces Fourth Quarter And Year End 2016 Financial Results And Conference Call Schedule", "publication_date": "2017-03-02 21:54:26 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-announces-215426272.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that the Company's management will issue its 2016 year-end financial and operating results on Friday, March 10th, 2017 at 6 AM EST. In conjunction with this ..." }, { "title": "Energy Sector Update for 01/27/2017: VVV,ESES,PER", "publication_date": "2017-01-27 21:11:14 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b7Hd3eXXjqE/energy-sector-update-for-01272017-vvvesesper-cm739624", "summary": "Top Energy StocksTop Energy Stocks XOM 0 22 XOM 0 22 CVX 2 47 CVX 2 47 COP 2 36 COP 2 36 SLB 0 52 SLB 0 52 OXY 0 52 OXY 0 52 Energy stocks were ending mostly lower today with the NYSE Energy Sector Index dropping just over 1 0 while shares of energy companies in the S amp P" }, { "title": "Energy Sector Update for 01/27/2017: EPE,APO,ESES,PER", "publication_date": "2017-01-27 17:51:14 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VZV4CPs1e_Y/energy-sector-update-for-01272017-epeapoesesper-cm739496", "summary": "Top Energy StocksTop Energy Stocks XOM 0 40 XOM 0 40 CVX 2 23 CVX 2 23 COP 2 11 COP 2 11 SLB 0 45 SLB 0 45 OXY 0 09 OXY 0 09 Energy stocks were mostly lower Friday with the NYSE Energy Sector Index dropping about 0 9 while shares of energy companies in the S amp P 500 also" }, { "title": "These 5 Stocks Under $10 Could Get Hot Soon", "publication_date": "2017-01-27 17:17:00 +0000", "url": "https://www.thestreet.com/story/13969723/1/these-5-stocks-under-10-could-get-hot-soon.html?puc=yahoo&cm_ven=YAHOO", "summary": "These 5 Stocks Under $10 Could Get Hot Soon" }, { "title": "Eco-Stim Energy Solutions Signs Contract To Expand Operations into Oklahoma", "publication_date": "2017-01-27 02:09:44 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-signs-020944681.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that the Company has executed a one-year contract, with an option for a second year, with a well-capitalized and established US exploration and production ..." }, { "title": "ETFs with exposure to Eco-Stim Energy Solutions, Inc. : December 29, 2016", "publication_date": "2016-12-29 18:51:20 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-eco-stim-energy-solutions-inc-december-29-2016/", "summary": "ETFs with exposure to Eco-Stim Energy Solutions, Inc. : December 29, 2016" }, { "title": "Energy Sector Update for 12/28/2016: SHLX,BP,UUUU,ESES", "publication_date": "2016-12-28 21:17:39 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AG6OKHuHDPw/energy-sector-update-for-12282016-shlxbpuuuueses-cm727153", "summary": "Top Energy StocksTop Energy Stocks XOM 0 44 XOM 0 44 CVX 0 20 CVX 0 20 COP 1 41 COP 1 41 SLB 0 90 SLB 0 90 OXY 0 53 OXY 0 53 Energy stocks sank Wednesday with the NYSE Energy Sector Index falling about 0 7 while shares of energy companies in the S amp P 500 were down 0 9 as" }, { "title": "Energy Sector Update for 12/28/2016: UUUU,XOM,ESES", "publication_date": "2016-12-28 18:57:53 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9rnO7t6J6as/energy-sector-update-for-12282016-uuuuxomeses-cm727090", "summary": "Top Energy StocksTop Energy Stocks XOM 0 09 XOM 0 09 CVX 0 11 CVX 0 11 COP 1 51 COP 1 51 SLB 0 82 SLB 0 82 OXY 0 61 OXY 0 61 Energy stocks were sinking Wednesday with the NYSE Energy Sector Index falling about 0 6 while shares of energy companies in the S amp P 500 were down 0" }, { "title": "6:04 am Eco-Stim Energy updates on the status of various contract opportunities as communicated in its most recent conference call in November; final outcomes of $75+ mln in Argentina-related contracts have not been concluded within the tim", "publication_date": "2016-12-28 11:04:00 +0000", "url": "http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#eses", "summary": "6:04 am Eco-Stim Energy updates on the status of various contract opportunities as communicated in its most recent conference call in November; final outcomes of $75+ mln in Argentina-related contracts have not been concluded within the tim" }, { "title": "Eco-Stim Energy Solutions Provides Update on Various Contract Opportunities", "publication_date": "2016-12-28 11:00:00 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-provides-110000048.html", "summary": "[Marketwired] - \"EcoStim\" or the \"Company\" , is providing a brief update on the status of various contract opportunities as communicated in the Company's most recent conference call in mid-November. ..." }, { "title": "ECO-STIM ENERGY SOLUTIONS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct", "publication_date": "2016-12-06 18:06:24 +0000", "url": "http://biz.yahoo.com/e/161206/eses8-k.html", "summary": "ECO-STIM ENERGY SOLUTIONS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct" }, { "title": "Eco-Stim Energy Solutions Secures $2 million Shareholder Loan", "publication_date": "2016-12-01 21:20:24 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-secures-212024889.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that it has finalized a $2 million secured loan from existing shareholders. The loan will have a one-year term with the proceeds used to prepay a $1 million ..." }, { "title": "Eco-Stim Energy Solutions to Present at Cowen and Company Energy & Natural Resources Conference", "publication_date": "2016-11-29 18:04:49 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-present-180449858.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that the Company will participate in the upcoming Cowen and Company Energy & Natural Resources Conference, which will be held December 6th and 7th, 2016 ..." }, { "title": "ECO-STIM ENERGY SOLUTIONS, INC. Financials", "publication_date": "2016-11-23 18:04:10 +0000", "url": "http://finance.yahoo.com/q/is?s=eses", "summary": "ECO-STIM ENERGY SOLUTIONS, INC. Financials" }, { "title": "Hayman Capital Closes Huge McDonalds (MCD) Put Position, Turns Its Bearish Gaze on This Health Stock", "publication_date": "2016-11-21 19:20:03 +0000", "url": "http://www.insidermonkey.com/blog/hayman-capital-closes-huge-mcdonalds-mcd-put-position-turns-its-bearish-gaze-on-this-health-stock-489176/", "summary": "Hayman Capital Closes Huge McDonalds (MCD) Put Position, Turns Its Bearish Gaze on This Health Stock" }, { "title": "Eco-Stim Energy Solutions, Inc. :ESES-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016", "publication_date": "2016-11-15 16:43:55 +0000", "url": "http://www.capitalcube.com/blog/index.php/eco-stim-energy-solutions-inc-eses-us-earnings-analysis-q3-2016-by-the-numbers-november-15-2016/", "summary": "Eco-Stim Energy Solutions, Inc. :ESES-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016" }, { "title": "Q3 2016 Eco-Stim Energy Solutions Inc Earnings Release - Before Market Open", "publication_date": "2016-11-14 12:07:03 +0000", "url": "http://biz.yahoo.com/research/earncal/20161114.html?t=eses", "summary": "Q3 2016 Eco-Stim Energy Solutions Inc Earnings Release - Before Market Open" }, { "title": "ECO-STIM ENERGY SOLUTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen", "publication_date": "2016-11-14 11:31:44 +0000", "url": "http://biz.yahoo.com/e/161114/eses8-k.html", "summary": "ECO-STIM ENERGY SOLUTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen" }, { "title": "EcoStim Energy Solutions Reports Third Quarter 2016 Results", "publication_date": "2016-11-14 11:00:00 +0000", "url": "http://finance.yahoo.com/news/ecostim-energy-solutions-reports-third-110000749.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today its financial and operating results for the three and nine months ended September 30, 2016." }, { "title": "Eco-Stim Energy Solutions Announces Timing of Third Quarter 2016 Financial Results and Conference Call", "publication_date": "2016-11-07 22:14:07 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-announces-221407921.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that the Company's management will issue its third quarter 2016 financial and operating results on Monday, November 14th, 2016 before the stock market opens. ..." }, { "title": "ETF’s with exposure to Eco-Stim Energy Solutions, Inc. : October 7, 2016", "publication_date": "2016-10-07 13:55:14 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-eco-stim-energy-solutions-inc-october-7-2016/", "summary": "ETF’s with exposure to Eco-Stim Energy Solutions, Inc. : October 7, 2016" }, { "title": "Eco-Stim Energy Solutions Completes Gas Turbine Pumping Fleet Enhancement and Executes First Well Stimulation Job Using This Disruptive New Technology", "publication_date": "2016-09-22 10:00:00 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-completes-100000904.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that it has completed the upgrade and automation on approximately 27,000 HHP of its turbine powered well stimulation units ." }, { "title": "Eco-Stim Energy Solutions Announces Election of Miguel Di Vincenzo as President of IAPG Houston", "publication_date": "2016-09-08 17:17:34 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-announces-171734643.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. today announced that Miguel Di Vincenzo, the Company's Vice President of Sales and Technology, has been elected as of July 26, 2016 to serve as the President of the Argentine ..." }, { "title": "Eco-Stim Energy Solutions to Participate in Pareto Securities 23rd Oil & Offshore Conference in Oslo, Norway September 14-15, 2016", "publication_date": "2016-09-07 20:45:18 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-participate-204518474.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that J. Chris Boswell, the Company's Chief Executive Officer, is scheduled to present a corporate overview at the upcoming Pareto Securities Oil & Offshore ..." }, { "title": "Kyle Bass Makes Huge Bet Against McDonald’s, Sells Off Clovis", "publication_date": "2016-09-06 11:58:54 +0000", "url": "http://www.insidermonkey.com/blog/kyle-bass-makes-huge-bet-against-mcdonalds-sells-off-clovis-472423/", "summary": "Kyle Bass Makes Huge Bet Against McDonald’s, Sells Off Clovis" }, { "title": "ETF’s with exposure to Eco-Stim Energy Solutions, Inc. : September 2, 2016", "publication_date": "2016-09-02 13:58:37 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-eco-stim-energy-solutions-inc-september-2-2016/", "summary": "ETF’s with exposure to Eco-Stim Energy Solutions, Inc. : September 2, 2016" }, { "title": "Eco-Stim Energy Solutions to Attend 2nd Annual TPCG Investor Trip in Buenos Aires, Argentina September 7-9, 2016", "publication_date": "2016-08-30 20:20:06 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-attend-202006627.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that J. Chris Boswell, the Company's President and Chief Executive Officer and Alexander Nickolatos, the Company's Chief Financial Officer, will attend the ..." }, { "title": "Eco-Stim Energy Solutions Announces Operational Start-up of Its Second Well Stimulation Crew", "publication_date": "2016-08-29 10:00:00 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-announces-100000075.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. , today announced that for the first time in the Company's short history, it has deployed two well stimulation crews at the same time. Following the arrival of its second ..." }, { "title": "Edited Transcript of ESES earnings conference call or presentation 15-Aug-16 2:00pm GMT", "publication_date": "2016-08-26 19:07:03 +0000", "url": "http://finance.yahoo.com/news/edited-transcript-eses-earnings-conference-190703521.html", "summary": "Edited Transcript of ESES earnings conference call or presentation 15-Aug-16 2:00pm GMT" }, { "title": "ETF’s with exposure to Eco-Stim Energy Solutions, Inc. : August 22, 2016", "publication_date": "2016-08-22 15:23:46 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-eco-stim-energy-solutions-inc-august-22-2016/", "summary": "ETF’s with exposure to Eco-Stim Energy Solutions, Inc. : August 22, 2016" }, { "title": "10 Oilfield Services Stocks to Ride Through an Upturn", "publication_date": "2016-08-19 16:58:00 +0000", "url": "https://www.thestreet.com/story/13680437/1/10-oilfield-services-stocks-to-ride-through-an-upturn.html?puc=yahoo&cm_ven=YAHOO", "summary": "10 Oilfield Services Stocks to Ride Through an Upturn" }, { "title": "Eco-Stim Energy Solutions, Inc. :ESES-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016", "publication_date": "2016-08-18 14:57:22 +0000", "url": "http://www.capitalcube.com/blog/index.php/eco-stim-energy-solutions-inc-eses-us-earnings-analysis-q2-2016-by-the-numbers-august-18-2016/", "summary": "Eco-Stim Energy Solutions, Inc. :ESES-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016" }, { "title": "Q2 2016 Eco-Stim Energy Solutions Inc Earnings Release - Before Market Open", "publication_date": "2016-08-15 11:07:02 +0000", "url": "http://biz.yahoo.com/research/earncal/20160815.html?t=eses", "summary": "Q2 2016 Eco-Stim Energy Solutions Inc Earnings Release - Before Market Open" }, { "title": "ECO-STIM ENERGY SOLUTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen", "publication_date": "2016-08-15 10:31:50 +0000", "url": "http://biz.yahoo.com/e/160815/eses8-k.html", "summary": "ECO-STIM ENERGY SOLUTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen" }, { "title": "EcoStim Energy Solutions Reports Second Quarter 2016 Results", "publication_date": "2016-08-15 10:00:00 +0000", "url": "http://finance.yahoo.com/news/ecostim-energy-solutions-reports-second-100000923.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today its financial and operating results for the three and six months ended June 30, 2016." }, { "title": "Pre-Market Earnings Report for August 15, 2016 : SYY, MSLI, VUZI, VBLT, SORL, ESES, CLSN, ASUR, CDTI, CLRB, FES", "publication_date": "2016-08-12 20:19:13 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5vNaxi7IYMg/pre-market-earnings-report-for-august-15-2016-syy-msli-vuzi-vblt-sorl-eses-clsn-asur-cdti-clrb-fes-cm664878", "summary": "The following companies are expected to report earnings prior to market open on 08 15 2016. Visit our Earnings Calendar for a full list of expected earnings releases. Sysco Corporation ( SYY ) is reporting for" }, { "title": "Oil Stocks Queued up for Q2 Earnings: NDRO, ESES, SDPI", "publication_date": "2016-08-11 13:53:43 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nm-Y9drN3KI/oil-stocks-queued-up-for-q2-earnings-ndro-eses-sdpi-cm664002", "summary": "We are now at the tail end of the second quarter earnings season, with 90.8% of the S&P 500 members having reported already (as of Aug 10).Q2 Earnings So Far So far, we have second quarter results from 454" }, { "title": "Oil Stocks Queued up for Q2 Earnings: NDRO, ESES, SDPI", "publication_date": "2016-08-11 12:40:12 +0000", "url": "http://finance.yahoo.com/news/oil-stocks-queued-q2-earnings-124012650.html", "summary": "Oil Stocks Queued up for Q2 Earnings: NDRO, ESES, SDPI" }, { "title": "Eco-Stim Energy Solutions Next Equipment Package Arrives at Operations Base in Neuquen City, Argentina", "publication_date": "2016-08-08 10:00:00 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-next-100000877.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. , today announced that the Company's recent shipment of equipment including its turbine powered pumping units and several pieces of supporting equipment have now cleared ..." }, { "title": "Eco-Stim Energy Solutions Announces Timing of Second Quarter 2016 Financial Results and Conference Call", "publication_date": "2016-07-25 16:20:47 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-announces-162047756.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that the Company's management will issue its second quarter 2016 financial and operating results on Monday, August 15th, 2016 at 6 AM EST. In conjunction ..." }, { "title": "Eco-Stim Energy Solutions Completes Downhole Diagnostics Evaluation; Awarded New Projects", "publication_date": "2016-07-21 21:35:09 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-completes-213509388.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that it has completed an initial downhole fiber optic well evaluation for a significant European-based exploration and production company in Argentina. This ..." }, { "title": "Energy Sector Update for 07/18/2016: IOT,ESES,PACD", "publication_date": "2016-07-18 20:26:02 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GSwTtQlf3xg/energy-sector-update-for-07182016-iotesespacd-cm650840", "summary": "Top Energy Stocks XOM 0.34% CVX 0.79% COP 0.66% SLB +0.18% OXY 0.78% Energy stocks were ending little changed, with the NYSE Energy Sector Index slipping about 0.1% while shares of energy companies in the S&P 500 were down" }, { "title": "Energy Sector Update for 07/18/2016: IOC,XOM,ESES,PACD", "publication_date": "2016-07-18 17:25:57 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GHsY03ReWCY/energy-sector-update-for-07182016-iocxomesespacd-cm650719", "summary": "Top Energy Stocks XOM 0.37% CVX 0.86% COP 0.93% SLB 0.27% OXY 0.90% Energy stocks were slightly lower today, with the NYSE Energy Sector Index slipping about 0.2% while shares of energy companies in the S&P 500 were down" }, { "title": "Coverage initiated on Eco-Stim Energy by Credit Suisse", "publication_date": "2016-07-18 12:17:29 +0000", "url": "http://finance.yahoo.com/q/ud?s=ESES", "summary": "Coverage initiated on Eco-Stim Energy by Credit Suisse" }, { "title": "ECO-STIM ENERGY SOLUTIONS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements", "publication_date": "2016-07-14 10:03:35 +0000", "url": "http://biz.yahoo.com/e/160714/eses8-k.html", "summary": "ECO-STIM ENERGY SOLUTIONS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements" }, { "title": "ECO-STIM ENERGY SOLUTIONS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders", "publication_date": "2016-07-06 19:36:30 +0000", "url": "http://biz.yahoo.com/e/160706/eses8-k.html", "summary": "ECO-STIM ENERGY SOLUTIONS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders" }, { "title": "Eco-Stim Energy Solutions Awarded New Contract for Well Stimulation and Coiled Tubing Businesses", "publication_date": "2016-05-26 20:39:28 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-awarded-203928778.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that it has been awarded a new contract with one of the largest and most active privately owned oil and gas operators in Argentina. This contract will cover ..." }, { "title": "Eco-Stim Energy Solutions Announces Participation in the Annual Louisiana Energy Conference to Be Held in New Orleans June 1-2, 2016", "publication_date": "2016-05-24 20:00:00 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-announces-200000092.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that J. Chris Boswell, the Company's President and Chief Executive Officer, will participate on a panel discussion at the Louisiana Energy Conference to ..." }, { "title": "Eco-Stim Energy Solutions, Inc. :ESES-US: Earnings Analysis: Q1, 2016 By the Numbers", "publication_date": "2016-05-17 18:39:52 +0000", "url": "http://www.capitalcube.com/blog/index.php/eco-stim-energy-solutions-inc-eses-us-earnings-analysis-q1-2016-by-the-numbers/", "summary": "Eco-Stim Energy Solutions, Inc. :ESES-US: Earnings Analysis: Q1, 2016 By the Numbers" }, { "title": "Eco-Stim Energy Solutions Reports First Quarter 2016 Results", "publication_date": "2016-05-12 21:40:57 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-reports-214057365.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today its financial and operating results for the quarter ended March 31, 2016." }, { "title": "Should You Buy Eco-Stim Energy (ESES) Ahead of Earnings?", "publication_date": "2016-05-11 14:30:27 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lT-FfZsL3tc/should-you-buy-eco-stim-energy-eses-ahead-of-earnings-cm619548", "summary": "Investors are always looking for stocks that are poised to beat at earnings season and Eco Stim Energy Solutions, Inc.ESES may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite" }, { "title": "Should You Buy Eco-Stim Energy (ESES) Ahead of Earnings?", "publication_date": "2016-05-11 12:38:12 +0000", "url": "http://finance.yahoo.com/news/buy-eco-stim-energy-eses-123812129.html", "summary": "Should You Buy Eco-Stim Energy (ESES) Ahead of Earnings?" }, { "title": "Petrobras (PBR): Will it Disappoint this Earnings Season?", "publication_date": "2016-05-10 16:30:57 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WRMEkhbcWfU/petrobras-pbr-will-it-disappoint-this-earnings-season-cm619055", "summary": "Brazilian state run energy giant Petroleo Brasileiro S.A. or PetrobrasPBR is expected to release first quarter 2016 results on Thursday, May 12.     Petrobras' earnings were a mixed bag in the trailing four quarters two beats and two misses" }, { "title": "Petrobras (PBR): Will it Disappoint this Earnings Season?", "publication_date": "2016-05-10 13:46:01 +0000", "url": "http://finance.yahoo.com/news/petrobras-pbr-disappoint-earnings-season-134601912.html", "summary": "Petrobras (PBR): Will it Disappoint this Earnings Season?" }, { "title": "Eco-Stim Energy Solutions Announces Timing of First Quarter 2016 Financial Results and Conference Call", "publication_date": "2016-05-03 20:00:00 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-announces-200000551.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that the Company's management will issue its first quarter 2016 financial and operating results on Thursday, May 12th, 2016 after the market closes. In conjunction ..." }, { "title": "Eco-Stim Energy Solutions Awarded Rotational On-Call Contract for Its Well Stimulation Business", "publication_date": "2016-04-11 10:00:00 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-awarded-100000533.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. announced today that it has been awarded a contract with one of the largest oil and gas operators in Argentina to provide well stimulation services in the province of Neuquén, ..." }, { "title": "Eco-Stim Energy Solutions to Present at 22nd IPAA OGIS Conference in New York", "publication_date": "2016-03-31 19:15:00 +0000", "url": "http://finance.yahoo.com/news/eco-stim-energy-solutions-present-191500651.html", "summary": "[Marketwired] - Eco-Stim Energy Solutions, Inc. today announced that J. Chris Boswell, the Company's chief executive officer, is scheduled to present a corporate overview at the upcoming 22nd IPAA Oil & Gas Investment ..." }, { "title": "Kyle Bass Takes Stake in Argentina-Focused Shale Company", "publication_date": "2015-07-25 16:26:31 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oXJeVeHNg-w/kyle-bass-takes-stake-in-argentina-focused-shale-company-cm499183", "summary": "Investor Kyle Bass ( Trades , Portfolio ) has procured a 17.1% stake in environmentally conscious unconventional shale oil company Eco Stim Energy Solutions ( ESES ) on July 10, he disclosed Monday. Bass' stake consisted of 2,105,263" }, { "title": "Oilfield services company Eco-Stim Energy files for a $25 million NASDAQ listing", "publication_date": "2014-11-17 15:20:47 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pDDukpAHJSU/oilfield-services-company-eco-stim-energy-files-for-a-25-million-nasdaq-listing-cm414527", "summary": "Eco Stim Energy Solutions, which provides well stimulation and completion services for upstream oil and gas companies, filed on Friday with the SEC to raise up to $25 million in a public offering. The company currently trades on the" } ], "result_count": 65, "page_size": 250, "current_page": 1, "total_pages": 1, "api_call_credits": 1 }, "chart":[{"values":[ {"x":"1489411800","y":"1.16"},{"x":"1489412100","y":"1.1385"},{"x":"1489412400","y":"1.1223"},{"x":"1489412700","y":"1.15"},{"x":"1489413000","y":"1.11"},{"x":"1489413300","y":"1.12"},{"x":"1489413600","y":"1.12"},{"x":"1489413900","y":"1.12"},{"x":"1489414200","y":"1.1245"},{"x":"1489414500","y":"1.1149"},{"x":"1489415100","y":"1.09"},{"x":"1489415400","y":"1.1"},{"x":"1489415700","y":"1.1"},{"x":"1489416000","y":"1.1123"},{"x":"1489416300","y":"1.11"},{"x":"1489416600","y":"1.1"},{"x":"1489416900","y":"1.1"},{"x":"1489417500","y":"1.1094"},{"x":"1489417800","y":"1.11"},{"x":"1489418100","y":"1.12"},{"x":"1489418400","y":"1.12"},{"x":"1489419000","y":"1.129"},{"x":"1489419300","y":"1.1299"},{"x":"1489419900","y":"1.11"},{"x":"1489420200","y":"1.1178"},{"x":"1489420800","y":"1.1156"},{"x":"1489421700","y":"1.1289"},{"x":"1489422300","y":"1.13"},{"x":"1489422900","y":"1.13"},{"x":"1489423500","y":"1.1112"},{"x":"1489424100","y":"1.12"},{"x":"1489424700","y":"1.129"},{"x":"1489425600","y":"1.13"},{"x":"1489425900","y":"1.13"},{"x":"1489426200","y":"1.1329"},{"x":"1489427100","y":"1.1400000000000001"},{"x":"1489427400","y":"1.15"},{"x":"1489427700","y":"1.1418"},{"x":"1489428000","y":"1.1401"},{"x":"1489428300","y":"1.1302"},{"x":"1489428600","y":"1.13"},{"x":"1489428900","y":"1.1219999999999999"},{"x":"1489429500","y":"1.1400000000000001"},{"x":"1489430100","y":"1.1400000000000001"},{"x":"1489431000","y":"1.121"},{"x":"1489431600","y":"1.1323"},{"x":"1489432200","y":"1.1400000000000001"},{"x":"1489432500","y":"1.1389"},{"x":"1489432800","y":"1.1320999999999999"},{"x":"1489433100","y":"1.1201"},{"x":"1489433400","y":"1.1216"},{"x":"1489433700","y":"1.1400000000000001"},{"x":"1489434000","y":"1.16"},{"x":"1489434300","y":"1.1502"},{"x":"1489434600","y":"1.15"},{"x":"1489434900","y":"1.1400000000000001"},{"x":"1489435200","y":"1.15"} ], "color":"#03a9f4"}]},
{"id":"3","list":"Calendar Movers","symbol": "OCUL","name": "Ocular Therapeutix I","price": 8.72,"dollarChange": 0.25,"percentChange": 2.96,"time":2.0,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/OCUL-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/OCUL-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/OCUL-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/OCUL-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/OCUL-1yr.php","open": 8.53,"high": 8.77,"low":8.1601,"volume": 669649,"avgVol": 1139258.666667,"sharesShort": 5936253,"shortPercent": 24.455411,"marketCap": 210046577,"float": 24273781,"headlines":{ "data": [ { "title": "Edited Transcript of OCUL earnings conference call or presentation 10-Mar-17 1:30pm GMT", "publication_date": "2017-03-10 23:25:01 +0000", "url": "http://finance.yahoo.com/news/edited-transcript-ocul-earnings-conference-232501843.html", "summary": "Edited Transcript of OCUL earnings conference call or presentation 10-Mar-17 1:30pm GMT" }, { "title": "Ocular Therapeutix Inc Earnings Call scheduled for 8:30 am ET today", "publication_date": "2017-03-10 13:30:00 +0000", "url": "http://biz.yahoo.com/cc/6/156066.html", "summary": "Ocular Therapeutix Inc Earnings Call scheduled for 8:30 am ET today" }, { "title": "Ocular Therapeutix reports 4Q loss", "publication_date": "2017-03-10 12:58:38 +0000", "url": "http://sg.finance.yahoo.com/news/ocular-therapeutix-reports-4q-loss-125838717.html", "summary": "Ocular Therapeutix reports 4Q loss" }, { "title": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E", "publication_date": "2017-03-10 12:36:55 +0000", "url": "http://biz.yahoo.com/e/170310/ocul8-k.html", "summary": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E" }, { "title": "Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2016 Financial Results", "publication_date": "2017-03-10 12:30:00 +0000", "url": "http://finance.yahoo.com/news/ocular-therapeutix-reports-fourth-quarter-123000593.html", "summary": "[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative drug products using its proprietary hydrogel platform technology for the treatment of diseases and conditions of the eye, today announced financial results for the fourth quarter of 2016 and the twelve months ended December 31, 2016." }, { "title": "Q4 2016 Ocular Therapeutix Inc Earnings Release - Before Market Open", "publication_date": "2017-03-10 12:07:05 +0000", "url": "http://biz.yahoo.com/research/earncal/20170310.html?t=ocul", "summary": "Q4 2016 Ocular Therapeutix Inc Earnings Release - Before Market Open" }, { "title": "Pre-Market Earnings Report for March 10, 2017 : MTN, PGEM, GCO, BKE, HIBB, TGLS, SRLP, CTRN, OCUL, KIRK, CNTY, VNRX", "publication_date": "2017-03-09 21:13:15 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NuG215VVAHE/pre-market-earnings-report-for-march-10-2017-mtn-pgem-gco-bke-hibb-tgls-srlp-ctrn-ocul-kirk-cnty-vnrx-cm758814", "summary": "The following companies are expected to report earnings prior to market open on 03 10 2017 Visit our Earnings Calendar for a full list of expected earnings releases Vail Resorts Inc MTN is reporting for the quarter ending January 31 2017 The" }, { "title": "Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2016 Financial Results", "publication_date": "2017-03-08 14:00:00 +0000", "url": "http://finance.yahoo.com/news/ocular-therapeutix-report-fourth-quarter-140000748.html", "summary": "[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2016, on Friday, March 10, 2017." }, { "title": "Biotech Movers And Shakers: Ocular Therapeutix Inc (OCUL) And Argos Therapeutics Inc (ARGS)", "publication_date": "2017-02-23 18:11:46 +0000", "url": "http://www.insidermonkey.com/blog/biotech-movers-and-shakers-ocular-therapeutix-inc-ocul-and-argos-therapeutics-inc-args-561892/", "summary": "Biotech Movers And Shakers: Ocular Therapeutix Inc (OCUL) And Argos Therapeutics Inc (ARGS)" }, { "title": "Blog Coverage Ocular Therapeutix Announced FDA Acceptance of NDA Resubmission for its Product for the Treatment of Ocular Pain", "publication_date": "2017-02-23 13:15:00 +0000", "url": "http://finance.yahoo.com/news/blog-coverage-ocular-therapeutix-announced-131500482.html", "summary": "[Accesswire] - Upcoming AWS Coverage on Alnylam Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / February 23, 2017 / Active Wall St. blog coverage looks at the headline from Ocular Therapeutix, Inc. (NASDAQ: ..." }, { "title": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events", "publication_date": "2017-02-22 13:11:15 +0000", "url": "http://biz.yahoo.com/e/170222/ocul8-k.html", "summary": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events" }, { "title": "8:05 am Ocular Therapeutix announces that the NDA resubmission for DEXTENZA 0.4 mg for intracanalicular use, for the treatment of ocular pain occurring after ophthalmic surgery has been accepted as a filing for review by the FDA", "publication_date": "2017-02-22 13:05:00 +0000", "url": "http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#ocul", "summary": "8:05 am Ocular Therapeutix announces that the NDA resubmission for DEXTENZA 0.4 mg for intracanalicular use, for the treatment of ocular pain occurring after ophthalmic surgery has been accepted as a filing for review by the FDA" }, { "title": "Ocular Therapeutix™ Announces FDA Acceptance of NDA Resubmission for DEXTENZA™ for the Treatment of Ocular Pain Occurring After Ophthalmic Surgery", "publication_date": "2017-02-22 13:00:00 +0000", "url": "http://finance.yahoo.com/news/ocular-therapeutix-announces-fda-acceptance-130000286.html", "summary": "[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Company’s New Drug Application resubmission for DEXTENZA™ 0.4 mg for intracanalicular use, for the treatment of ocular pain occurring after ophthalmic surgery has been accepted as a filing for review by the U.S...." }, { "title": "Why Ocular Therapeutix Inc Jumped Higher Today", "publication_date": "2017-02-10 23:18:13 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JlIEFjwyuZs/why-ocular-therapeutix-inc-jumped-higher-today-cm746591", "summary": "What happened Ocular Therapeutix NASDAQ OCUL closed up 17 7 today after Cantor Fitzgerald initiated coverage on the biotech with an overweight rating and a price target of 35 Image source Getty Images So what Analyst Elemer Piros is excited about" }, { "title": "Why Ocular Therapeutix Inc Jumped Higher Today", "publication_date": "2017-02-10 21:30:57 +0000", "url": "http://www.fool.com/investing/2017/02/10/why-ocular-therapeutix-inc-jumped-higher-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2", "summary": "Why Ocular Therapeutix Inc Jumped Higher Today" }, { "title": "Ocular TherapeutixTM to Present at Three Upcoming Investor Conferences", "publication_date": "2017-02-09 21:05:00 +0000", "url": "http://finance.yahoo.com/news/ocular-therapeutixtm-present-three-upcoming-210500128.html", "summary": "[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye," }, { "title": "SV Life Sciences Advisers, LLC Buys KalVista Pharmaceuticals, Sells Raptor Pharmaceutical", "publication_date": "2017-02-08 09:17:03 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CFilzlAQTgo/sv-life-sciences-advisers-llc-buys-kalvista-pharmaceuticals-sells-raptor-pharmaceutical-cm744623", "summary": "SV Life Sciences Advisers LLC New Purchases KALV Reduced Positions OCUL Sold Out RPTP New Purchases KALV New Purchases KALV Reduced Positions OCUL Reduced Positions OCUL Sold Out RPTP Sold Out" }, { "title": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State", "publication_date": "2017-01-25 21:32:10 +0000", "url": "http://biz.yahoo.com/e/170125/ocul8-k.html", "summary": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State" }, { "title": "ETFs with exposure to Ocular Therapeutix, Inc. : January 25, 2017", "publication_date": "2017-01-25 18:27:55 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-january-25-2017/", "summary": "ETFs with exposure to Ocular Therapeutix, Inc. : January 25, 2017" }, { "title": "Gainers & Losers Of The Day: GNVC, NVIV, CLRB. AQB, BIOA...", "publication_date": "2017-01-25 00:26:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7IkfIqdddxg/gainers--losers-of-the-day-gnvc-nviv-clrb-aqb-bioa-20170125-00009", "summary": "Gainers & Losers Of The Day: GNVC, NVIV, CLRB. AQB, BIOA..." }, { "title": "Tuesday Sector Laggards: Drugs, Waste Management Stocks", "publication_date": "2017-01-24 20:31:45 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h7EIGTayCLQ/tuesday-sector-laggards-drugs-waste-management-stocks-cm737586", "summary": "In trading on Tuesday drugs shares were relative laggards down on the day by about 0 6 Helping drag down the group were shares of Ocular Therapeutix OCUL off about 9 and shares of Novan NOVN off about 6 7 on the day Also lagging the market Tuesday are waste" }, { "title": "Ocular Therapeutics Sinks Following Secondary Offering", "publication_date": "2017-01-24 20:13:59 +0000", "url": "http://finance.yahoo.com/news/ocular-therapeutics-sinks-following-secondary-201359317.html", "summary": "Ocular Therapeutics Sinks Following Secondary Offering" }, { "title": "Health Care Sector Update for 01/24/2017: OCUL,RMD,BIOA", "publication_date": "2017-01-24 19:31:13 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5dOQlQnl7w0/health-care-sector-update-for-01242017-oculrmdbioa-cm737557", "summary": "Top Health Care StocksTop Health Care Stocks JNJ 1 69 JNJ 1 69 PFE 1 14 PFE 1 14 MRK 0 17 MRK 0 17 ABT 1 04 ABT 1 04 AMGN 0 75 AMGN 0 75 Health care stocks were the lone industry sector in the S amp P 500 declining Tuesday with the NYSE Health Care Index dropping 0 7 while" }, { "title": "Ocular Therapeutix, Inc. Announces Pricing of Public Offering of Common Stock", "publication_date": "2017-01-24 13:00:00 +0000", "url": "http://finance.yahoo.com/news/ocular-therapeutix-inc-announces-pricing-130000530.html", "summary": "[Business Wire] - Ocular Therapeutix, Inc. announced today the pricing of a registered underwritten public offering of 3,571,429 shares of its common stock at a public offering price of $7.00 per share pursuant to a shelf registration statement that was previously filed with and declared effective by the Securities and Exchange Commission ." }, { "title": "Ocular Therapeutix, Inc. Announces Public Offering of Common Stock", "publication_date": "2017-01-23 21:01:00 +0000", "url": "http://finance.yahoo.com/news/ocular-therapeutix-inc-announces-public-210100203.html", "summary": "[Business Wire] - Ocular Therapeutix, Inc. announced today that it has commenced a registered underwritten public offering of $25 million of shares of its common stock pursuant to a shelf registration statement that was previously filed with and declared effective by the Securities and Exchange Commission ." }, { "title": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events", "publication_date": "2017-01-23 13:26:20 +0000", "url": "http://biz.yahoo.com/e/170123/ocul8-k.html", "summary": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events" }, { "title": "Ocular Therapeutix™ Resubmits NDA for DEXTENZA™ for the Treatment of Ocular Pain Occurring After Ophthalmic Surgery", "publication_date": "2017-01-23 13:15:00 +0000", "url": "http://finance.yahoo.com/news/ocular-therapeutix-resubmits-nda-dextenza-131500560.html", "summary": "[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it has resubmitted a New Drug Application to the U.S." }, { "title": "ETFs with exposure to Ocular Therapeutix, Inc. : January 9, 2017", "publication_date": "2017-01-09 18:53:40 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-january-9-2017/", "summary": "ETFs with exposure to Ocular Therapeutix, Inc. : January 9, 2017" }, { "title": "6 Major FDA Decisions and Biopharma Catalysts Coming in January and February", "publication_date": "2017-01-06 15:25:51 +0000", "url": "http://finance.yahoo.com/news/6-major-fda-decisions-biopharma-152551867.html", "summary": "6 Major FDA Decisions and Biopharma Catalysts Coming in January and February" }, { "title": "Ocular (OCUL) Reports Positive Phase III Data on Eye Drug", "publication_date": "2017-01-05 16:39:29 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t_8-mg02eRk/ocular-ocul-reports-positive-phase-iii-data-on-eye-drug-cm729808", "summary": "Shares of Ocular Therapeutix Inc OCUL were up 3 following the company s announcement of positive results from its third phase III trial on lead pipeline candidate 160 Dextenza 0 4 mg for the treatment of post surgical ocular inflammation and pain Notably Ocular has outperformed" }, { "title": "Ocular (OCUL) Reports Positive Phase III Data on Eye Drug", "publication_date": "2017-01-05 14:40:02 +0000", "url": "http://finance.yahoo.com/news/ocular-ocul-reports-positive-phase-144002716.html", "summary": "Ocular (OCUL) Reports Positive Phase III Data on Eye Drug" }, { "title": "Ocular Therapeutix Pulls Back Off Early Highs But Remains Positive", "publication_date": "2017-01-04 14:00:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pGnE-otwNkw/ocular-therapeutix-pulls-back-off-early-highs-but-remains-positive-20170104-00906", "summary": "Ocular Therapeutix Pulls Back Off Early Highs But Remains Positive" }, { "title": "Ocular Therapeutix™ Announces Additional Successful Results for Phase 3 Clinical Trial of DEXTENZA™", "publication_date": "2017-01-04 13:33:18 +0000", "url": "http://www.publicnow.com/view/5E7320396AAFAB4FD9C427DA54FC70FC418C9B4B", "summary": "[at noodls] - Statistically significant secondary endpoint of absence of ocular flare confirms further evidence of reduction of inflammation BEDFORD, Mass.--(BUSINESS WIRE)--Jan. 4, 2017-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), ..." }, { "title": "Ocular Therapeutix™ Announces Additional Successful Results for Phase 3 Clinical Trial of DEXTENZA™", "publication_date": "2017-01-04 13:00:00 +0000", "url": "http://finance.yahoo.com/news/ocular-therapeutix-announces-additional-successful-130000823.html", "summary": "[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced additional positive secondary endpoint results from its most recent successful phase 3 clinical trial of DEXTENZA™ 0.4 mg, for the treatment of post-surgical ocular inflammation and pain." }, { "title": "ETFs with exposure to Ocular Therapeutix, Inc. : December 30, 2016", "publication_date": "2016-12-30 16:18:54 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-december-30-2016/", "summary": "ETFs with exposure to Ocular Therapeutix, Inc. : December 30, 2016" }, { "title": "7 Key FDA Decisions and Catalysts Expected in January and February", "publication_date": "2016-12-30 12:45:32 +0000", "url": "http://247wallst.com/healthcare-business/2016/12/30/7-key-fda-decisions-and-catalysts-expected-in-january-and-february/", "summary": "7 Key FDA Decisions and Catalysts Expected in January and February" }, { "title": "How Ocular Therapeutix Inc (OCUL) Stacks Up Against Its Peers", "publication_date": "2016-12-16 04:50:38 +0000", "url": "http://www.insidermonkey.com/blog/how-ocular-therapeutix-inc-ocul-stacks-up-against-its-peers-510998/", "summary": "How Ocular Therapeutix Inc (OCUL) Stacks Up Against Its Peers" }, { "title": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events", "publication_date": "2016-12-14 21:38:32 +0000", "url": "http://biz.yahoo.com/e/161214/ocul8-k.html", "summary": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events" }, { "title": "ETFs with exposure to Ocular Therapeutix, Inc. : December 8, 2016", "publication_date": "2016-12-08 17:53:17 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-december-8-2016/", "summary": "ETFs with exposure to Ocular Therapeutix, Inc. : December 8, 2016" }, { "title": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State", "publication_date": "2016-11-30 11:05:13 +0000", "url": "http://biz.yahoo.com/e/161130/ocul8-k.html", "summary": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State" }, { "title": "ETFs with exposure to Ocular Therapeutix, Inc. : November 28, 2016", "publication_date": "2016-11-28 17:23:43 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-november-28-2016/", "summary": "ETFs with exposure to Ocular Therapeutix, Inc. : November 28, 2016" }, { "title": "Stocks Pull Back Following Recent Upward Trend - U.S. Commentary", "publication_date": "2016-11-28 16:22:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EKbjuwCY_Ug/stocks-pull-back-following-recent-upward-trend--us-commentary-20161128-00816", "summary": "Stocks Pull Back Following Recent Upward Trend - U.S. Commentary" }, { "title": "Stocks Stuck In Negative Territory In Mid-Day Trading - U.S. Commentary", "publication_date": "2016-11-28 11:57:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IGuhb8uiXkk/stocks-stuck-in-negative-territory-in-midday-trading--us-commentary-20161128-00597", "summary": "Stocks Stuck In Negative Territory In Mid-Day Trading - U.S. Commentary" }, { "title": "Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016", "publication_date": "2016-11-23 15:15:32 +0000", "url": "http://www.capitalcube.com/blog/index.php/ocular-therapeutix-inc-ocul-us-earnings-analysis-q3-2016-by-the-numbers-november-23-2016/", "summary": "Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016" }, { "title": "OCULAR THERAPEUTIX, INC Financials", "publication_date": "2016-11-17 18:04:24 +0000", "url": "http://finance.yahoo.com/q/is?s=ocul", "summary": "OCULAR THERAPEUTIX, INC Financials" }, { "title": "FDA Snubs DVAX, Keep An Eye On OCUL, It''s All Green For BLUE", "publication_date": "2016-11-15 01:21:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5kdvVrziyXY/fda-snubs-dvax-keep-an-eye-on-ocul-its-all-green-for-blue-20161115-00027", "summary": "FDA Snubs DVAX, Keep An Eye On OCUL, It''s All Green For BLUE" }, { "title": "FDA Snubs DVAX, Keep An Eye On OCUL, It's All Green For BLUE", "publication_date": "2016-11-15 01:21:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_6PcBqSY1LI/fda-snubs-dvax-keep-an-eye-on-ocul-its-all-green-for-blue-20161115-00028", "summary": "FDA Snubs DVAX, Keep An Eye On OCUL, It's All Green For BLUE" }, { "title": "Notable Monday Option Activity: PBYI, OCUL, REGN", "publication_date": "2016-11-14 22:28:59 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WUnVjKRfg6o/notable-monday-option-activity-pbyi-ocul-regn-cm709018", "summary": "Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Puma Biotechnology Inc Symbol PBYI where a total volume of 6 622 contracts has been traded thus far today a contract volume which is representative of approximately 662" }, { "title": "Ocular Therapeutix surges 14% on positive early clinical trial results", "publication_date": "2016-11-14 13:27:34 +0000", "url": "http://www.marketwatch.com/News/Story/Story.aspx?guid=E3840D42-0736-4155-8BAE-87B8CC0D9CB0&siteid=yhoof2", "summary": "Ocular Therapeutix surges 14% on positive early clinical trial results" }, { "title": "Ocular Therapeutix™ Announces Successful Topline Results for Both Inflammation and Pain Primary Efficacy Endpoints from Phase 3 Clinical Trial of DEXTENZA™", "publication_date": "2016-11-14 12:17:10 +0000", "url": "http://www.publicnow.com/view/7517A269454E2A126B06DF097D7898E40CC43172", "summary": "[at noodls] - Conference Call Today at 8:30 am Eastern Time BEDFORD, Mass.--(BUSINESS WIRE)--Nov. 14, 2016-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization ..." }, { "title": "Edited Transcript of OCUL earnings conference call or presentation 9-Nov-16 1:30pm GMT", "publication_date": "2016-11-10 04:53:39 +0000", "url": "http://finance.yahoo.com/news/edited-transcript-ocul-earnings-conference-045339894.html", "summary": "Edited Transcript of OCUL earnings conference call or presentation 9-Nov-16 1:30pm GMT" }, { "title": "ADAP Surges As FDA Lifts Clinical Hold, OCUL Catches Eyes, RegeneRx On The Rise", "publication_date": "2016-11-10 01:57:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dQSDgHm_C-g/adap-surges-as-fda-lifts-clinical-hold-ocul-catches-eyes-regenerx-on-the-rise-20161110-00064", "summary": "ADAP Surges As FDA Lifts Clinical Hold, OCUL Catches Eyes, RegeneRx On The Rise" }, { "title": "Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences", "publication_date": "2016-11-09 21:21:23 +0000", "url": "http://www.publicnow.com/view/EB0DDECAEFBD690F170A079189D3B682625DD428", "summary": "[at noodls] - BEDFORD, Mass.--(BUSINESS WIRE)--Nov. 9, 2016-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases ..." }, { "title": "Ocular Therapeutix™ Reports Third Quarter 2016 Financial Results and Provides Corporate Update", "publication_date": "2016-11-09 12:19:07 +0000", "url": "http://www.publicnow.com/view/4FE7765B8C6D45494EEB4D15127700163AD103CD", "summary": "[at noodls] - Preparing to Resubmit NDA for DEXTENZA™ for the Treatment of Ocular Pain Occurring After Ophthalmic Surgery to FDA by the End of 2016 Began Enrollment in First Phase 3 Clinical Trial with OTX-TP (Sustained ..." }, { "title": "Ocular Therapeutix reports 3Q loss", "publication_date": "2016-11-09 12:16:45 +0000", "url": "http://sg.finance.yahoo.com/news/ocular-therapeutix-reports-3q-loss-121645124.html", "summary": "Ocular Therapeutix reports 3Q loss" }, { "title": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E", "publication_date": "2016-11-09 12:08:59 +0000", "url": "http://biz.yahoo.com/e/161109/ocul8-k.html", "summary": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E" }, { "title": "Q3 2016 Ocular Therapeutix Inc Earnings Release - Before Market Open", "publication_date": "2016-11-09 12:07:06 +0000", "url": "http://biz.yahoo.com/research/earncal/20161109.html?t=ocul", "summary": "Q3 2016 Ocular Therapeutix Inc Earnings Release - Before Market Open" }, { "title": "Ocular Therapeutix™ to Hold Third Quarter 2016 Financial Results Conference Call on Wednesday, November 9, 2016", "publication_date": "2016-11-02 12:10:14 +0000", "url": "http://www.publicnow.com/view/AF67AB9350DF21CF73F1160BE9C3F8F5B5092B39", "summary": "[at noodls] - BEDFORD, Mass.--(BUSINESS WIRE)--Nov. 2, 2016-- Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases ..." }, { "title": "Ocular Therapeutix™ Strengthens Management Team with the Appointment of Andy Hurley as Chief Commercial Officer", "publication_date": "2016-10-20 12:19:06 +0000", "url": "http://www.publicnow.com/view/5164756D1046F4395E323AFC05FD71CEBBEF46B9", "summary": "[at noodls] - BEDFORD, Mass--(BUSINESS WIRE)--Oct. 20, 2016-- Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases ..." }, { "title": "Ocular's (OCUL) Stock Jumps on Collaboration with Regeneron", "publication_date": "2016-10-14 16:42:44 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n17cqIkYVZ8/oculars-ocul-stock-jumps-on-collaboration-with-regeneron-cm693506", "summary": "Regeneron Pharmaceuticals Inc REGN and Ocular Therapeutix Inc OCUL announced a strategic collaboration and option and license agreement for the development of a sustained release formulation of Regeneron s Eylea aflibercept for the treatment of wet age related macular degeneration" }, { "title": "Ocular's (OCUL) Stock Jumps on Collaboration with Regeneron", "publication_date": "2016-10-14 14:27:02 +0000", "url": "http://finance.yahoo.com/news/oculars-ocul-stock-jumps-collaboration-142702904.html", "summary": "Ocular's (OCUL) Stock Jumps on Collaboration with Regeneron" }, { "title": "Blog Coverage Ocular Therapeutix Announces a Potential 315 Million Dollar Drug Development Deal with Regeneron Pharma", "publication_date": "2016-10-14 13:11:40 +0000", "url": "http://news.investornetwork.com/2016/10/14/blog-coverage-ocular-therapeutix-announces-a-potential-315-million-dollar-drug-development-deal-with-regeneron-pharma/?1=1&1476450700", "summary": "Blog Coverage Ocular Therapeutix Announces a Potential 315 Million Dollar Drug Development Deal with Regeneron Pharma" }, { "title": "Close Update: Downbeat Chinese Trade Data Weighs on Wall Street", "publication_date": "2016-10-13 21:00:50 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uBJSnMiS2R4/close-update-downbeat-chinese-trade-data-weighs-on-wall-street-cm693161", "summary": "Stocks closed with modest losses on Thursday but off their worst levels of the day when disappointing trade data from China rekindled worries about the world s second largest economy and a 43 year low in initial jobless claims raised the odds for a December rate hike The Dow was trading" }, { "title": "Regeneron, Ocular to Develop Eye Drug (REGN, OCUL)", "publication_date": "2016-10-13 20:13:00 +0000", "url": "http://www.investopedia.com/news/regeneron-ocular-enter-315m-deal-regn-ocul/?partner=YahooSA", "summary": "Regeneron, Ocular to Develop Eye Drug (REGN, OCUL)" }, { "title": "Midday Update: Wall Street Spooked by Downbeat Chinese Trade Data", "publication_date": "2016-10-13 17:20:59 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cIy_gSJJ2X4/midday-update-wall-street-spooked-by-downbeat-chinese-trade-data-cm693039", "summary": "Stocks continue to trade with sizable losses on Thursday after investors fled risky assets in the wake of disappointing Chinese trade data and a 43 year low in new U S unemployment claims The Dow Jones Industrial Average and S amp P 500 fell to their lowest levels in more than 3 months on" }, { "title": "Regeneron: Today is the Greatest Day I've Ever Known", "publication_date": "2016-10-13 16:51:00 +0000", "url": "http://blogs.barrons.com/stockstowatchtoday/2016/10/13/regeneron-today-is-the-greatest-day-ive-ever-known/?mod=yahoobarrons&ru=yahoo", "summary": "Regeneron: Today is the Greatest Day I've Ever Known" }, { "title": "Ocular Therapeutix (OCUL) Stock Soars on Regeneron Deal", "publication_date": "2016-10-13 16:05:00 +0000", "url": "https://www.thestreet.com/story/13852486/1/ocular-therapeutix-ocul-stock-soars-on-regeneron-deal.html?puc=yahoo&cm_ven=YAHOO", "summary": "Ocular Therapeutix (OCUL) Stock Soars on Regeneron Deal" }, { "title": "Here’s Why Amazon, Alphabet, Ocular Therapeutix, and Two Other Stocks Are Trending on Thursday", "publication_date": "2016-10-13 15:16:29 +0000", "url": "http://www.insidermonkey.com/blog/heres-why-amazon-alphabet-ocular-therapeutix-and-two-other-stocks-are-trending-on-thursday-481049/", "summary": "Here’s Why Amazon, Alphabet, Ocular Therapeutix, and Two Other Stocks Are Trending on Thursday" }, { "title": "Bedford's Ocular Therapeutix inks potential $315M deal with Regeneron", "publication_date": "2016-10-13 14:48:46 +0000", "url": "http://www.bizjournals.com/boston/blog/bioflash/2016/10/bedfords-ocular-therapeutix-inks-potential-315m.html?ana=yahoo", "summary": "Bedford's Ocular Therapeutix inks potential $315M deal with Regeneron" }, { "title": "Stock Futures Turn Defensive as China Trade Disappoints, Initial Claims Fall to 43-Year Low", "publication_date": "2016-10-13 13:41:06 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4CTS09VXPv0/stock-futures-turn-defensive-as-china-trade-disappoints-initial-claims-fall-to-43-year-low-cm692721", "summary": "U S stock futures were building on earlier losses as the number of Americans filing unemployment claims fell to a 43 year low and China s disappointing trade data rekindled investors concerns about the state of the world s second largest economy U S stock futures were building on earlier" }, { "title": "Ocular Therapeutix stock up 26% on $10 mln Regeneron drug development deal", "publication_date": "2016-10-13 13:22:12 +0000", "url": "http://www.marketwatch.com/News/Story/Story.aspx?guid=6CE8029F-A8F0-4F45-9868-F39708EDB6FB&siteid=yhoof2", "summary": "Ocular Therapeutix stock up 26% on $10 mln Regeneron drug development deal" }, { "title": "Why Ocular Therapeutix Is Winning Big With Its Regeneron Collaboration", "publication_date": "2016-10-13 13:05:59 +0000", "url": "http://247wallst.com/healthcare-business/2016/10/13/why-ocular-therapeutix-is-winning-big-with-its-regeneron-collaboration/", "summary": "Why Ocular Therapeutix Is Winning Big With Its Regeneron Collaboration" }, { "title": "Pre-Market Most Active for Oct 13, 2016 : ERIC, SNY, LYG, OCUL, NOK, MT, XIV, RBS, MSFT, QQQ, FCX, TVIX", "publication_date": "2016-10-13 13:00:28 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tCunonxOO0E/pre-market-most-active-for-oct-13-2016-eric-sny-lyg-ocul-nok-mt-xiv-rbs-msft-qqq-fcx-tvix-cm692711", "summary": "The NASDAQ 100 Pre Market Indicator is down 15 22 to 4 804 41 The total Pre Market volume is currently 10 104 006 shares traded The following are the most active stocks for the pre market session Ericsson ERIC is 0 04 at 5 59 with 2 684 667 shares traded" }, { "title": "Ocular Therapeutix Inc Conference Call to Provide Updates on Back of the Eye Programs scheduled for 8:30 am ET today", "publication_date": "2016-10-13 12:30:00 +0000", "url": "http://biz.yahoo.com/cc/4/154184.html", "summary": "Ocular Therapeutix Inc Conference Call to Provide Updates on Back of the Eye Programs scheduled for 8:30 am ET today" }, { "title": "Ocular Therapeutix™ and Regeneron Enter Into Strategic Collaboration to Develop Sustained Release Formulation of Aflibercept for the Treatment of Wet AMD and Other Serious Retinal Diseases", "publication_date": "2016-10-13 11:20:07 +0000", "url": "http://www.publicnow.com/view/D52CC833F4191DE1B386DCB8D3BE907D2D4952BD", "summary": "[at noodls] - Sustained Release Formulation Has Potential to Significantly Advance Current Standard of Care by Reducing Injection Frequency in the Treatment of Wet AMD Ocular Therapeutix Eligible to Receive up to $305 ..." }, { "title": "Ocular Therapeutix™ Outlines Development Strategy for Its Sustained Release Intravitreal Depots to Address Serious Retinal Diseases", "publication_date": "2016-10-13 11:20:07 +0000", "url": "http://www.publicnow.com/view/2F5EFEEDCBAAAC50C6A9D909D0C54CDCDF541672", "summary": "[at noodls] - New Strategic Collaboration with Regeneron to Develop Sustained Release Formulation of Aflibercept for the Treatment of Wet AMD and Other Serious Retinal Diseases Ocular Therapeutix Selected to Present ..." }, { "title": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement", "publication_date": "2016-10-13 11:07:06 +0000", "url": "http://biz.yahoo.com/e/161013/ocul8-k.html", "summary": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement" }, { "title": "Ocular Therapeutix and Regeneron Sign Research Agreement", "publication_date": "2016-10-13 08:59:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qS3xlEgFBh4/ocular-therapeutix-and-regeneron-sign-research-agreement-20161013-00536", "summary": "Ocular Therapeutix and Regeneron Sign Research Agreement" }, { "title": "Ocular Therapeutix Signs Strategic Collaboration With Regeneron Pharma", "publication_date": "2016-10-13 07:29:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WzvVOSjCuJk/ocular-therapeutix-signs-strategic-collaboration-with-regeneron-pharma-20161013-00290", "summary": "Ocular Therapeutix Signs Strategic Collaboration With Regeneron Pharma" }, { "title": "ETF’s with exposure to Ocular Therapeutix, Inc. : October 6, 2016", "publication_date": "2016-10-06 14:07:19 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-october-6-2016/", "summary": "ETF’s with exposure to Ocular Therapeutix, Inc. : October 6, 2016" }, { "title": "Ocular Begins Enrollment in Phase III Trial on Glaucoma Drug", "publication_date": "2016-10-05 15:47:51 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/weu9xfbGbTg/ocular-begins-enrollment-in-phase-iii-trial-on-glaucoma-drug-cm689083", "summary": "Ocular Therapeutix Inc OCUL announced the enrollment of the first patient in one of the two planned phase III clinical trials on its pipeline candidate OTX TP sustained release travoprost for the treatment of glaucoma and ocular hypertension The U S based prospective" }, { "title": "Ocular Begins Enrollment in Phase III Trial on Glaucoma Drug", "publication_date": "2016-10-05 14:02:02 +0000", "url": "http://finance.yahoo.com/news/ocular-begins-enrollment-phase-iii-140202968.html", "summary": "Ocular Begins Enrollment in Phase III Trial on Glaucoma Drug" }, { "title": "CATB Data Pushed Back To Q1, SMMT At Peak, TRIB Pounded, OTIC Hits Right Notes", "publication_date": "2016-10-05 01:04:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qCD762Mut_8/catb-data-pushed-back-to-q1-smmt-at-peak-trib-pounded-otic-hits-right-notes-20161005-00016", "summary": "CATB Data Pushed Back To Q1, SMMT At Peak, TRIB Pounded, OTIC Hits Right Notes" }, { "title": "Ocular Therapeutix™ Begins Enrollment in First Phase 3 Clinical Trial with OTX-TP (Sustained Release Travoprost) for the Treatment of Glaucoma and Ocular Hypertension", "publication_date": "2016-10-04 20:38:05 +0000", "url": "http://www.publicnow.com/view/50AD97936DE4B6952FFBF70A1C8EA97489512771", "summary": "[at noodls] - Phase 3 study design to compare OTX-TP with placebo inserts; no timolol validation arm required Refined product design shows significant improvement in patient retention over 3-month duration BEDFORD, ..." }, { "title": "Lifshitz & Miller Law Firm Announces Investigation of AECOM, American Farmland Company, Centene Corp., Cepheid, Cray Inc., Echo Global Logistics, Inc., Ocular Therapeutix, Inc., and Pure Storage, Inc.", "publication_date": "2016-09-13 19:18:00 +0000", "url": "http://finance.yahoo.com/news/lifshitz-miller-law-firm-announces-191800344.html", "summary": "[PR Newswire] - NEW YORK, Sept. 13, 2016 /PRNewswire/ -- AECOM (ACM) Lifshitz & Miller announces investigation on behalf of AECOM investors. Specifically, Spruce Point Capital Management published a report stating that ..." }, { "title": "ETF’s with exposure to Ocular Therapeutix, Inc. : September 13, 2016", "publication_date": "2016-09-13 14:46:22 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-september-13-2016/", "summary": "ETF’s with exposure to Ocular Therapeutix, Inc. : September 13, 2016" }, { "title": "Ocular Therapeutix™ to Participate in the Morgan Stanley Global Healthcare Conference", "publication_date": "2016-08-31 20:05:00 +0000", "url": "http://finance.yahoo.com/news/ocular-therapeutix-participate-morgan-stanley-200500372.html", "summary": "[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016 at 4:15 p.m." }, { "title": "ETF’s with exposure to Ocular Therapeutix, Inc. : August 29, 2016", "publication_date": "2016-08-29 15:54:38 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-august-29-2016/", "summary": "ETF’s with exposure to Ocular Therapeutix, Inc. : August 29, 2016" }, { "title": "ETF’s with exposure to Ocular Therapeutix, Inc. : August 16, 2016", "publication_date": "2016-08-16 16:31:24 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-august-16-2016/", "summary": "ETF’s with exposure to Ocular Therapeutix, Inc. : August 16, 2016" }, { "title": "Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016", "publication_date": "2016-08-15 17:43:07 +0000", "url": "http://www.capitalcube.com/blog/index.php/ocular-therapeutix-inc-ocul-us-earnings-analysis-q2-2016-by-the-numbers-august-15-2016/", "summary": "Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016" }, { "title": "5 Biohealth Stocks Rising 10% or More on News", "publication_date": "2016-08-11 17:05:41 +0000", "url": "http://247wallst.com/healthcare-business/2016/08/11/5-biohealth-stocks-rising-10-or-more-on-news/", "summary": "5 Biohealth Stocks Rising 10% or More on News" }, { "title": "Coverage initiated on Ocular Therapeutix by JMP Securities", "publication_date": "2016-08-11 11:34:25 +0000", "url": "http://finance.yahoo.com/q/ud?s=OCUL", "summary": "Coverage initiated on Ocular Therapeutix by JMP Securities" }, { "title": "Edited Transcript of OCUL earnings conference call or presentation 9-Aug-16 12:30pm GMT", "publication_date": "2016-08-09 17:56:55 +0000", "url": "http://finance.yahoo.com/news/edited-transcript-ocul-earnings-conference-175655066.html", "summary": "Edited Transcript of OCUL earnings conference call or presentation 9-Aug-16 12:30pm GMT" }, { "title": "Ocular Therapeutix Inc Earnings Call scheduled for 8:30 am ET today", "publication_date": "2016-08-09 12:30:00 +0000", "url": "http://biz.yahoo.com/cc/0/153460.html", "summary": "Ocular Therapeutix Inc Earnings Call scheduled for 8:30 am ET today" }, { "title": "Ocular Therapeutix reports 2Q loss", "publication_date": "2016-08-09 11:53:35 +0000", "url": "http://sg.finance.yahoo.com/news/ocular-therapeutix-reports-2q-loss-115335303.html", "summary": "Ocular Therapeutix reports 2Q loss" }, { "title": "Ocular Therapeutix™ Reports Second Quarter 2016 Financial Results and Provides Corporate Update", "publication_date": "2016-08-09 11:50:04 +0000", "url": "http://www.publicnow.com/view/A02E3EB01B4F79CD4CE7892EDBA1EEED0EAF8B3A", "summary": "[at noodls] - Conference call today at 8:30 am Eastern Time BEDFORD, Mass.--(BUSINESS WIRE)--Aug. 9, 2016-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization ..." }, { "title": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E", "publication_date": "2016-08-09 11:37:37 +0000", "url": "http://biz.yahoo.com/e/160809/ocul8-k.html", "summary": "OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E" }, { "title": "Q2 2016 Ocular Therapeutix Inc Earnings Release - Before Market Open", "publication_date": "2016-08-09 11:07:03 +0000", "url": "http://biz.yahoo.com/research/earncal/20160809.html?t=ocul", "summary": "Q2 2016 Ocular Therapeutix Inc Earnings Release - Before Market Open" }, { "title": "A Handful of Biotech Stocks Plunge After Disappointing Results", "publication_date": "2016-08-08 20:51:05 +0000", "url": "http://finance.yahoo.com/news/handful-biotech-stocks-plunge-disappointing-205105977.html", "summary": "A Handful of Biotech Stocks Plunge After Disappointing Results" }, { "title": "These 7 Stocks Under $10 Are Making Big Moves Higher", "publication_date": "2016-08-05 12:56:00 +0000", "url": "https://www.thestreet.com/story/13666340/1/these-7-stocks-under-10-are-making-big-moves-higher.html?puc=yahoo&cm_ven=YAHOO", "summary": "These 7 Stocks Under $10 Are Making Big Moves Higher" }, { "title": "Ocular Therapeutix™ Announces Presentation at the Ophthalmology Innovation Summit (OIS) at the American Society of Retina Specialists (ASRS)", "publication_date": "2016-08-05 12:24:08 +0000", "url": "http://www.publicnow.com/view/888B8DE4600A854C2F54D567E06EBB05AC945893", "summary": "[at noodls] - Presentation to highlight preclinical data supporting the Company's proprietary sustained release technology for intravitreal injections BEDFORD, Mass--(BUSINESS WIRE)--Aug. 5, 2016-- Ocular Therapeutix, ..." }, { "title": "Why is Ocular Therapeutics (OCUL) Surging 36% Today?", "publication_date": "2016-08-04 21:52:39 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y578HfLyf-8/why-is-ocular-therapeutics-ocul-surging-36-today-cm660741", "summary": "Ocular Therapeutics OCUL is up 34.8% in afternoon trading after announcing that the FDA's concerns regarding the company's New Drug Application (NDA) appear to have been addressed. Based in Bedford, MA, OCUL is a biopharmaceutical company that focuses on" }, { "title": "Why is Ocular Therapeutics (OCUL) Surging 36% Today?", "publication_date": "2016-08-04 19:49:07 +0000", "url": "http://finance.yahoo.com/news/why-ocular-therapeutics-ocul-surging-194907426.html", "summary": "Why is Ocular Therapeutics (OCUL) Surging 36% Today?" }, { "title": "Midday Update: Stocks Turn Neutral Ahead of Labor Market Report", "publication_date": "2016-08-04 17:29:07 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Sg5BqmvGqc/midday-update-stocks-turn-neutral-ahead-of-labor-market-report-cm660580", "summary": "The Dow Jones Industrial Average was straddling the flat line Thursday while the S&P 500 and Nasdaq were clinging onto modest gains as the excitement that followed the Bank of England's rate cut evaporated and investors squared up positions" }, { "title": "Ocular Therapeutix (OCL) Stock Soars, FDA: Corrective Actions Address Concerns", "publication_date": "2016-08-04 16:38:00 +0000", "url": "https://www.thestreet.com/story/13665332/1/ocular-therapeutix-ocl-stock-soars-fda-corrective-actions-address-concerns.html?puc=yahoo&cm_ven=YAHOO", "summary": "Ocular Therapeutix (OCL) Stock Soars, FDA: Corrective Actions Address Concerns" }, { "title": "Ocular Therapeutix™ Provides Update on NDA for DEXTENZA™ for the Treatment of Post-Surgical Ocular Pain", "publication_date": "2016-08-03 20:12:11 +0000", "url": "http://www.publicnow.com/view/7A8524F1605187B4B5B8BF5995D53E9F0CA40089", "summary": "[at noodls] - One outstanding item remains pertaining to manufacturing process and controls BEDFORD, Mass.--(BUSINESS WIRE)--Aug. 3, 2016-- Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused ..." }, { "title": "IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Ocular Therapeutix, Inc. and Reminds Investors with Losses to Contact the Firm", "publication_date": "2016-08-03 10:35:00 +0000", "url": "http://finance.yahoo.com/news/important-shareholder-alert-khang-khang-103500457.html", "summary": "[Business Wire] - Khang & Khang LLP announces that it is investigating claims against Ocular Therapeutix, Inc. concerning possible violations of federal securities laws." }, { "title": "Ocular Therapeutix™ to Report Second Quarter 2016 Financial Results", "publication_date": "2016-08-02 20:32:07 +0000", "url": "http://www.publicnow.com/view/C8FE1C57822EA80C1F5D1FE94F40770F1B57B208", "summary": "[at noodls] - BEDFORD, Mass--(BUSINESS WIRE)--Aug. 2, 2016-- Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases ..." }, { "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ocular Therapeutix, Inc. - OCUL", "publication_date": "2016-08-02 18:16:00 +0000", "url": "http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-181600042.html", "summary": "[Accesswire] - NEW YORK, NY / ACCESSWIRE / August 2, 2016 / Pomerantz LLP is investigating claims on behalf of investors of Ocular Therapeutix, Inc. (\"Ocular\" or the \"Company\") (NASDAQ: OCUL). Such ..." }, { "title": "IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Ocular Therapeutix, Inc. and Advises Investors with Losses to Contact the Firm", "publication_date": "2016-08-01 14:43:00 +0000", "url": "http://finance.yahoo.com/news/important-shareholder-alert-lundin-law-144300840.html", "summary": "[Business Wire] - Lundin Law PC announces it is investigating claims against Ocular Therapeutix concerning possible violations of federal securities laws." }, { "title": "Glancy Prongay & Murray Commences Investigation on Behalf of Ocular Therapeutix, Inc. Investors", "publication_date": "2016-07-29 19:31:00 +0000", "url": "http://finance.yahoo.com/news/glancy-prongay-murray-commences-investigation-193100006.html", "summary": "[Business Wire] - Glancy Prongay & Murray LLP announces an investigation on behalf of investors of Ocular Therapeutix, Inc. concerning the Company and its officers’ possible violations of federal securities laws." }, { "title": "IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces An Investigation of Claims Against Ocular Therapeutix, Inc. And Advises Investors With Losses To Contact The Firm", "publication_date": "2016-07-27 22:14:00 +0000", "url": "http://finance.yahoo.com/news/important-shareholder-notice-goldberg-law-221400891.html", "summary": "[Business Wire] - Goldberg Law PC announces that it is investigating claims of potential misrepresentations by Ocular Therapeutix, Inc. ." }, { "title": "SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding Possible Violations of Federal Securities Laws by Certain Officers and Directors of Ocular Therapeutix Inc.", "publication_date": "2016-07-27 20:02:00 +0000", "url": "http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-200200936.html", "summary": "[Business Wire] - Levi & Korsinsky announces it has commenced an investigation of Ocular Therapeutix Inc. concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors." }, { "title": "Good News For GNVC, ACRS On Track, TBRA Tanks, FDA Says No To OCUL", "publication_date": "2016-07-26 00:47:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oyqpXLRIxpo/good-news-for-gnvc-acrs-on-track-tbra-tanks-fda-says-no-to-ocul-20160726-00005", "summary": "Good News For GNVC, ACRS On Track, TBRA Tanks, FDA Says No To OCUL" }, { "title": "Pre-Market Most Active for Jul 25, 2016 : AZN, S, YHOO, SMFG, TKC, SNY, MU, RDS/B, OCUL, XIV, FB, BLPH", "publication_date": "2016-07-25 13:07:04 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OUthqxEwTGg/pre-market-most-active-for-jul-25-2016-azn-s-yhoo-smfg-tkc-sny-mu-rdsb-ocul-xiv-fb-blph-cm653932", "summary": "The NASDAQ 100 Pre Market Indicator is up 2.45 to 4,668.52. The total Pre Market volume is currently 5,530,003 shares traded. The following are the most active stocks for the pre market session Astrazeneca PLC ( AZN ) is" }, { "title": "Ocular Therapeutix™ Receives Complete Response Letter from FDA for its NDA for DEXTENZA™ for the Treatment of Post-Surgical Ocular Pain", "publication_date": "2016-07-25 12:08:00 +0000", "url": "http://www.publicnow.com/view/6A852197AC4F47AFF16941272D22C145094127F1", "summary": "[at noodls] - No efficacy or safety issues raised by FDA Outstanding items pertain to manufacturing process and controls BEDFORD, Mass.--(BUSINESS WIRE)--Jul. 25, 2016-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical ..." }, { "title": "Ocular Therapeutix™ to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference", "publication_date": "2016-07-06 12:11:09 +0000", "url": "http://www.publicnow.com/view/B55B90A32DDE0E3522913560B8407FADE7D37F34", "summary": "[at noodls] - BEDFORD, Mass.--(BUSINESS WIRE)--Jul. 6, 2016-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases ..." }, { "title": "Biotech Stocks Facing FDA Decision In July", "publication_date": "2016-06-30 06:19:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-eOv98I5puw/biotech-stocks-facing-fda-decision-in-july-20160630-00140", "summary": "Biotech Stocks Facing FDA Decision In July" }, { "title": "ADMP Snubbed Again, OCUL, DNAI Skid On Trial Data, AGN Gets FDA Nod. SRPT Abuzz", "publication_date": "2016-06-07 01:56:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R0lid86hsxY/admp-snubbed-again-ocul-dnai-skid-on-trial-data-agn-gets-fda-nod-srpt-abuzz-20160607-00028", "summary": "ADMP Snubbed Again, OCUL, DNAI Skid On Trial Data, AGN Gets FDA Nod. SRPT Abuzz" }, { "title": "Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences", "publication_date": "2016-06-02 20:25:04 +0000", "url": "http://www.publicnow.com/view/AD0804E63353DB15BD968607D09D1ADCD6174F7A", "summary": "[at noodls] - BEDFORD, Mass.--(BUSINESS WIRE)--Jun. 2, 2016-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases ..." }, { "title": "Ocular Therapeutix™ Reports First Quarter 2016 Financial Results and Provides Corporate Update", "publication_date": "2016-05-10 11:18:10 +0000", "url": "http://www.publicnow.com/view/43F8C7DAEB52990BE18028FF8401E3A036ECB89A", "summary": "[at noodls] - PDUFA target action date of July 24, 2016 for DEXTENZA™ NDA for the treatment of post-surgical ocular pain Second Phase 3 clinical trial for DEXTENZA for the treatment of allergic conjunctivitis fully ..." }, { "title": "Ocular Therapeutix reports 1Q loss", "publication_date": "2016-05-10 11:08:38 +0000", "url": "http://sg.finance.yahoo.com/news/ocular-therapeutix-reports-1q-loss-110838283.html", "summary": "Ocular Therapeutix reports 1Q loss" }, { "title": "Ocular Therapeutix™ to Report First Quarter 2016 Financial Results", "publication_date": "2016-05-03 20:20:05 +0000", "url": "http://www.publicnow.com/view/BE7A2511FB59D400FAE51F0BEBFA28AE62C0C51B", "summary": "[at noodls] - BEDFORD, Mass.--(BUSINESS WIRE)--May 3, 2016-- Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases ..." }, { "title": "Ocular TherapeutixTM Completes End-of-Phase 2 Review with FDA for OTX-TP (Sustained Release Travoprost) for Glaucoma and Ocular Hypertension", "publication_date": "2016-04-27 20:27:34 +0000", "url": "http://www.publicnow.com/view/C63853F1111B54048B7668A2B45CE26F79B2F2FF", "summary": "[at noodls] - First Phase 3 trial expected to commence in the third quarter of 2016 Trial design to evaluate OTX-TP using placebo as comparator; no timolol validation arm required BEDFORD, Mass.--(BUSINESS WIRE)--Apr. ..." }, { "title": "Analysts Anticipate IWV To Hit $133", "publication_date": "2016-04-13 12:58:55 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pyw0wd7DtnI/analysts-anticipate-iwv-to-hit-133-cm605628", "summary": "Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average" }, { "title": "Can The Uptrend Continue for Ocular Therapeutix (OCUL)?", "publication_date": "2016-04-05 16:06:16 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ljx5WONQeo4/can-the-uptrend-continue-for-ocular-therapeutix-ocul-cm601894", "summary": "Investors certainly have to be happy with Ocular Therapeutix Inc OCUL and its short term performance. After all, the stock has jumped by 13.2% in the past 4 weeks, and it is also above its 20 Day Simple Moving" }, { "title": "Ocular TherapeutixTM to Host Investor Day on April 6, 2016", "publication_date": "2016-03-28 20:22:35 +0000", "url": "http://www.publicnow.com/view/572D0AF16603945811C5606FB6A81B994C489306", "summary": "[at noodls] - BEDFORD, Mass.--(BUSINESS WIRE)--Mar. 28, 2016-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases ..." }, { "title": "Ocular Therapeutix reports 4Q loss", "publication_date": "2016-03-10 12:15:37 +0000", "url": "http://sg.finance.yahoo.com/news/ocular-therapeutix-reports-4q-loss-121537856.html", "summary": "Ocular Therapeutix reports 4Q loss" }, { "title": "Closing Update: Stocks Extend Rally to Third Day Supported by Rising Oil Price, Improving Factory Output", "publication_date": "2016-02-17 21:43:28 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_e5k3_Yoi5c/closing-update-stocks-extend-rally-to-third-day-supported-by-rising-oil-price-improving-factory-output-cm581191", "summary": "Stocks rose for a third day in a row Wednesday, posting their best gains so far in 2016 as crude oil continued its recovery after minutes from the most recent Federal Open Markets Committee meeting indicated Federal Reserve policy" }, { "title": "Health Care Sector Update for 02/17/2016: FLXN,OCUL,CPRX", "publication_date": "2016-02-17 21:20:12 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q6lKJnMw3hY/health-care-sector-update-for-02172016-flxnoculcprx-cm581186", "summary": "Top Health Care Stocks JNJ +0.14% PZE 0.39% MRK +1.20% ABT +1.59% AMGN +2.28% Health care stocks were mostly higher today, with the NYSE Health Care Index rising about 1.2% while shares of health care companies in the S&P" }, { "title": "Health Care Sector Update for 02/17/2016: CERN,OCUL,CPRX", "publication_date": "2016-02-17 18:00:10 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OzFiHcEC7oI/health-care-sector-update-for-02172016-cernoculcprx-cm581013", "summary": "Top Health Care Stocks JNJ +0.17% PZE 0.02% MRK +1.33% ABT +1.39% AMGN +2.22% Health care stocks were mostly higher, with the NYSE Health Care Index rising about 1.0% while shares of health care companies in the S&P 500" }, { "title": "Ocular TherapeutixTM Strengthens Executive Management Team with the Appointment of Highly Regarded Ophthalmologist Jonathan H. Talamo, M.D., as Chief Medical Officer", "publication_date": "2016-01-11 12:17:19 +0000", "url": "http://www.noodls.com/view/B67ACDD5F1EC82071B57F18635FD6C2631D8CF25", "summary": "[at noodls] - --(BUSINESS WIRE)--Jan. 11, 2016-- (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced ..." }, { "title": "Ocular Therapeutix (OCUL) Shares March Higher, Can It Continue?", "publication_date": "2015-12-21 17:18:47 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iPDfys_GyNM/ocular-therapeutix-ocul-shares-march-higher-can-it-continue-cm557146", "summary": "As of late, it has definitely been a great time to be an investor in Ocular Therapeutix Inc OCUL . The stock has moved higher by 26.2% in the past month, while it is also above its 20 Day" }, { "title": "Ocular Therapeutix, Inc. (Nasdaq: OCUL) to Ring The Nasdaq Stock Market Opening Bell", "publication_date": "2015-12-14 14:02:24 +0000", "url": "http://www.noodls.com/view/F27FD3C49394EC684BA5149238111D9705CDD59B", "summary": "[at noodls] - What: Ocular Therapeutix, Inc. (Nasdaq: OCUL), a biopharmaceutical company creating innovative therapies for diseases and conditions of the eye, will visit the Nasdaq MarketSite in Times Square. In honor ..." }, { "title": "Ocular Therapeutix™ Announces Encouraging Top-Line Results from Exploratory Phase 2 Trial for DEXTENZA™ in Patients with Inflammatory Dry Eye Disease", "publication_date": "2015-12-14 12:32:24 +0000", "url": "http://www.noodls.com/view/DF1CC0E0778019452DC5ABB24ACB919BB57D9D91", "summary": "[at noodls] - DEXTENZA showed benefit in efficacy measure of corneal staining signs of inflammatory dry eye disease for total corneal staining change from baseline at day 30 Supportive measures of conjunctival staining ..." }, { "title": "Ocular Therapeutix, Inc. (Nasdaq: OCUL) to Ring the Nasdaq Stock Market Opening Bell", "publication_date": "2015-12-11 15:06:30 +0000", "url": "http://www.noodls.com/view/2DECB8BF2E99301E850F91369961BAD205005904", "summary": "[at noodls] - ADVISORY, Dec. 11, 2015 (GLOBE NEWSWIRE) -- What: Ocular Therapeutix, Inc. (Nasdaq:OCUL), a biopharmaceutical company creating innovative therapies for diseases and conditions of the eye, will visit the ..." }, { "title": "Ocular Therapeutix™ Announces FDA Acceptance of NDA Filing for DEXTENZA™ for the Treatment of Post-Surgical Ocular Pain", "publication_date": "2015-12-09 13:32:01 +0000", "url": "http://www.noodls.com/view/DF89126611FB0C25A838E8BA3BE2F4BB87943C0E", "summary": "[at noodls] - PDUFA target action date of July 24, 2016 DEXTENZA initial target indication comprises over 5 million ocular surgeries BEDFORD, Mass.--(BUSINESS WIRE)--Dec. 9, 2015-- Ocular Therapeutix™, Inc. (NASDAQ:OCUL), ..." }, { "title": "Ocular Begins Second Phase III Allergic Conjunctivitis Study", "publication_date": "2015-11-26 20:36:11 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gf0UeQMSsU0/ocular-begins-second-phase-iii-allergic-conjunctivitis-study-cm547665", "summary": "Pipeline updates are highly awaited events in the pharma biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give" }, { "title": "Ocular Therapeutix™ to Present at the Piper Jaffray 27th Annual Healthcare Conference", "publication_date": "2015-11-24 21:17:28 +0000", "url": "http://www.noodls.com/view/C919C1CA202C8169E36E56673F451E7CA214F628", "summary": "[at noodls] - BEDFORD, Mass.--(BUSINESS WIRE)--Nov. 24, 2015-- Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases ..." }, { "title": "Ocular Therapeutix™ Begins Enrollment in its Second Phase 3 Clinical Trial for DEXTENZA™ for the Treatment of Allergic Conjunctivitis", "publication_date": "2015-11-24 13:33:23 +0000", "url": "http://www.noodls.com/view/42F7F14A6E4E4A667412802FDA6F493935DFFBB5", "summary": "[at noodls] - BEDFORD, Mass.--(BUSINESS WIRE)--Nov. 24, 2015-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases ..." }, { "title": "Ocular Therapeutix reports 3Q loss", "publication_date": "2015-11-10 21:39:46 +0000", "url": "http://sg.finance.yahoo.com/news/ocular-therapeutix-reports-3q-loss-213946477.html", "summary": "Ocular Therapeutix reports 3Q loss" }, { "title": "Ocular Therapeutix™ Reports Third Quarter 2015 Financial Results", "publication_date": "2015-11-10 21:36:15 +0000", "url": "http://www.noodls.com/view/E09A1A11D27387960B23A38099B9ED97C0F5ED8C", "summary": "[at noodls] - Advances in Clinical Programs Include NDA Submission for DEXTENZA™ (sustained release dexamethasone, 0.4mg) for the Treatment of Post-Surgical Ocular Pain Results Reported for Phase 3 Allergic Conjunctivitis ..." }, { "title": "Ocular Therapeutix™ Expands Its Board of Directors with the Election of Industry Leader W. James O’Shea", "publication_date": "2015-11-09 21:26:20 +0000", "url": "http://www.noodls.com/view/536D11F323381449E35BF03F1E40C08C920E03CC", "summary": "[at noodls] - BEDFORD, Mass.--(BUSINESS WIRE)--Nov. 9, 2015-- Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases ..." }, { "title": "Ocular Therapeutix (OCUL) Enters Oversold Territory", "publication_date": "2015-10-29 12:44:07 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3zS7jtrNips/ocular-therapeutix-ocul-enters-oversold-territory-cm536121", "summary": "Ocular Therapeutix Inc OCUL has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking" }, { "title": "Health Care Sector Update for 10/23/2015: OCUL,IG,MMSI", "publication_date": "2015-10-23 20:00:16 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sphZ7V_cA1Q/health-care-sector-update-for-10232015-oculigmmsi-cm534028", "summary": "Top Health Care Stocks JNJ +1.24% PZE +2.93% MRK +0.51% ABT +2.25% AMGN +2.25% Health care stocks posted big gains, with the NYSE Health Care Index jumping more than 2.5% while shares of health care companies in the S&P" }, { "title": "Ocular (OCUL) Initiates Third Phase III Study on Dextenza", "publication_date": "2015-10-21 22:44:05 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/amBkALvKk4Q/ocular-ocul-initiates-third-phase-iii-study-on-dextenza-cm533108", "summary": "Ocular Therapeutix, Inc.OCUL announced the initiation of patient enrolment in the third phase III study on Dextenza (sustained release dexamethasone) for the treatment of post surgical ocular inflammation and pain. The prospective, multicenter, randomized, parallel arm, double masked, vehicle" }, { "title": "Health Care Sector Update for 08/13/2015: OCUL, IMUC", "publication_date": "2015-08-13 20:01:22 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dMrhT6Jm5Ew/health-care-sector-update-for-08132015-ocul-imuc-cm508951", "summary": "Top Health care stocks JNJ 0.1% PFE +0.3% ABT 0.3% MRK +1.7% AMGN flat Health care shares were mixed in Thursday's late afternoon trading session. In health care stocks news, analysts at Morgan Stanley initiated coverage of Ocular Therapeutix" }, { "title": "Ocular Therapeutix (OCUL) in Focus: Stock Goes Down 6.4% - Tale of the Tape", "publication_date": "2015-04-10 16:15:56 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c_B3Lxhx7vU/ocular-therapeutix-ocul-in-focus-stock-goes-down-64-tale-of-the-tape-cm464175", "summary": "Ocular Therapeutix, Inc. ( OCUL ) saw a big move in the last trading session, as the company's shares fell by over 6% on the day. The move came on pretty good volume too with far more shares changing" }, { "title": "Ocular Therapeutix slumps on eye treatment study", "publication_date": "2015-04-06 22:12:50 +0000", "url": "http://sg.finance.yahoo.com/news/ocular-therapeutix-slumps-eye-treatment-221250857.html", "summary": "Ocular Therapeutix slumps on eye treatment study" } ], "result_count": 149, "page_size": 250, "current_page": 1, "total_pages": 1, "api_call_credits": 1 }, "chart":[{"values":[ {"x":"1489411800","y":"8.48"},{"x":"1489412100","y":"8.35"},{"x":"1489412400","y":"8.29"},{"x":"1489412700","y":"8.34"},{"x":"1489413000","y":"8.26"},{"x":"1489413300","y":"8.26"},{"x":"1489413600","y":"8.17"},{"x":"1489413900","y":"8.22"},{"x":"1489414200","y":"8.26"},{"x":"1489414500","y":"8.315"},{"x":"1489414800","y":"8.3753"},{"x":"1489415100","y":"8.42"},{"x":"1489415400","y":"8.47"},{"x":"1489415700","y":"8.57"},{"x":"1489416000","y":"8.68"},{"x":"1489416300","y":"8.66"},{"x":"1489416600","y":"8.74"},{"x":"1489416900","y":"8.7"},{"x":"1489417200","y":"8.65"},{"x":"1489417500","y":"8.68"},{"x":"1489417800","y":"8.71"},{"x":"1489418100","y":"8.66"},{"x":"1489418400","y":"8.64"},{"x":"1489418700","y":"8.7"},{"x":"1489419000","y":"8.69"},{"x":"1489419300","y":"8.7"},{"x":"1489419600","y":"8.666"},{"x":"1489419900","y":"8.645"},{"x":"1489420200","y":"8.56"},{"x":"1489420500","y":"8.57"},{"x":"1489420800","y":"8.61"},{"x":"1489421100","y":"8.61"},{"x":"1489421400","y":"8.62"},{"x":"1489421700","y":"8.605"},{"x":"1489422000","y":"8.6"},{"x":"1489422300","y":"8.59"},{"x":"1489422600","y":"8.605"},{"x":"1489422900","y":"8.5715"},{"x":"1489423200","y":"8.6"},{"x":"1489423500","y":"8.6"},{"x":"1489423800","y":"8.61"},{"x":"1489424100","y":"8.61"},{"x":"1489424400","y":"8.61"},{"x":"1489424700","y":"8.58"},{"x":"1489425000","y":"8.59"},{"x":"1489425300","y":"8.56"},{"x":"1489425600","y":"8.56"},{"x":"1489425900","y":"8.57"},{"x":"1489426200","y":"8.565"},{"x":"1489426500","y":"8.5936"},{"x":"1489426800","y":"8.6"},{"x":"1489427100","y":"8.6101"},{"x":"1489427400","y":"8.64"},{"x":"1489427700","y":"8.66"},{"x":"1489428000","y":"8.69"},{"x":"1489428300","y":"8.695"},{"x":"1489428600","y":"8.695"},{"x":"1489428900","y":"8.6901"},{"x":"1489429200","y":"8.6936"},{"x":"1489429500","y":"8.72"},{"x":"1489429800","y":"8.735"},{"x":"1489430100","y":"8.74"},{"x":"1489430400","y":"8.73"},{"x":"1489430700","y":"8.71"},{"x":"1489431000","y":"8.735"},{"x":"1489431300","y":"8.71"},{"x":"1489431600","y":"8.72"},{"x":"1489431900","y":"8.7"},{"x":"1489432200","y":"8.72"},{"x":"1489432500","y":"8.725"},{"x":"1489432800","y":"8.729"},{"x":"1489433100","y":"8.725"},{"x":"1489433400","y":"8.7401"},{"x":"1489433700","y":"8.7301"},{"x":"1489434000","y":"8.735"},{"x":"1489434300","y":"8.735"},{"x":"1489434600","y":"8.74"},{"x":"1489434900","y":"8.73"},{"x":"1489435200","y":"8.72"} ], "color":"#03a9f4"}]},
{"id":"4","list":"Calendar Movers","symbol": "TELL","name": "Tellurian Inc. - Com","price": 11.85,"dollarChange": 1.87,"percentChange": 18.74,"time":4.0,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/TELL-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/TELL-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/TELL-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/TELL-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/TELL-1yr.php","open": 9.94,"high": 12.6,"low":9.85,"volume": 3068772,"avgVol": 1069219.238095,"sharesShort": 0,"shortPercent": 0.000000,"marketCap": 3560979451,"float": 197230550,"headlines":{ "data": [], "result_count": 0, "page_size": 250, "current_page": 1, "total_pages": 0, "api_call_credits": 1 }, "chart":[{"values":[ {"x":"1489411800","y":"10.4816"},{"x":"1489412100","y":"10.92"},{"x":"1489412400","y":"10.67"},{"x":"1489412700","y":"10.606"},{"x":"1489413000","y":"10.5468"},{"x":"1489413300","y":"10.56"},{"x":"1489413600","y":"10.65"},{"x":"1489413900","y":"10.65"},{"x":"1489414200","y":"10.8003"},{"x":"1489414500","y":"10.99"},{"x":"1489414800","y":"11.2"},{"x":"1489415100","y":"11.14"},{"x":"1489415400","y":"11.31"},{"x":"1489415700","y":"11.34"},{"x":"1489416000","y":"11.44"},{"x":"1489416300","y":"11.53"},{"x":"1489416600","y":"11.5"},{"x":"1489416900","y":"11.5"},{"x":"1489417200","y":"11.59"},{"x":"1489417500","y":"11.51"},{"x":"1489417800","y":"11.5892"},{"x":"1489418100","y":"11.56"},{"x":"1489418400","y":"11.7499"},{"x":"1489418700","y":"11.935"},{"x":"1489419000","y":"11.87"},{"x":"1489419300","y":"11.62"},{"x":"1489419600","y":"11.63"},{"x":"1489419900","y":"11.71"},{"x":"1489420200","y":"11.68"},{"x":"1489420500","y":"11.66"},{"x":"1489420800","y":"11.93"},{"x":"1489421100","y":"11.905"},{"x":"1489421400","y":"11.96"},{"x":"1489421700","y":"12.25"},{"x":"1489422000","y":"12.08"},{"x":"1489422300","y":"12.14"},{"x":"1489422600","y":"12.16"},{"x":"1489422900","y":"12"},{"x":"1489423200","y":"12.24"},{"x":"1489423500","y":"12.35"},{"x":"1489423800","y":"12.315"},{"x":"1489424100","y":"12.36"},{"x":"1489424400","y":"12.46"},{"x":"1489424700","y":"12.4001"},{"x":"1489425000","y":"12.2401"},{"x":"1489425300","y":"12.16"},{"x":"1489425600","y":"11.91"},{"x":"1489425900","y":"11.92"},{"x":"1489426200","y":"12.01"},{"x":"1489426500","y":"11.97"},{"x":"1489426800","y":"12.11"},{"x":"1489427100","y":"11.88"},{"x":"1489427400","y":"11.815"},{"x":"1489427700","y":"11.7501"},{"x":"1489428000","y":"11.83"},{"x":"1489428300","y":"11.6511"},{"x":"1489428600","y":"11.67"},{"x":"1489428900","y":"11.74"},{"x":"1489429200","y":"11.58"},{"x":"1489429500","y":"11.59"},{"x":"1489429800","y":"11.7378"},{"x":"1489430100","y":"11.66"},{"x":"1489430400","y":"11.75"},{"x":"1489430700","y":"11.61"},{"x":"1489431000","y":"11.69"},{"x":"1489431300","y":"11.74"},{"x":"1489431600","y":"11.72"},{"x":"1489431900","y":"11.715"},{"x":"1489432200","y":"11.75"},{"x":"1489432500","y":"11.72"},{"x":"1489432800","y":"11.64"},{"x":"1489433100","y":"11.4311"},{"x":"1489433400","y":"11.5"},{"x":"1489433700","y":"11.6"},{"x":"1489434000","y":"11.7"},{"x":"1489434300","y":"11.815"},{"x":"1489434600","y":"11.77"},{"x":"1489434900","y":"11.79"},{"x":"1489435200","y":"11.85"} ], "color":"#03a9f4"}]},
{"id":"5","list":"Calendar Movers","symbol": "UEC","name": "Uranium Energy Corp","price": 1.33,"dollarChange": 0.03,"percentChange": 1.53,"time":4.0,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/UEC-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/UEC-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/UEC-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/UEC-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/UEC-1yr.php","open": 1.3,"high": 1.3599999999999999,"low":1.28,"volume": 1149378,"avgVol": 2910575.854167,"sharesShort": 13560828,"shortPercent": 10.680031,"marketCap": 201450069,"float": 126973680,"headlines":{ "data": [ { "title": "Uranium Energy reports 2Q loss", "publication_date": "2017-03-13 10:12:39 +0000", "url": "http://sg.finance.yahoo.com/news/uranium-energy-reports-2q-loss-101239538.html", "summary": "Uranium Energy reports 2Q loss" }, { "title": "Uranium Energy Corp Files Fiscal 2017 Q2 Report", "publication_date": "2017-03-13 10:05:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-files-fiscal-100500048.html", "summary": "[CNW Group] - Uranium Energy Corp Files Fiscal 2017 Q2 Report" }, { "title": "URANIUM ENERGY CORP Files SEC form 10-Q, Quarterly Report", "publication_date": "2017-03-13 10:04:59 +0000", "url": "http://biz.yahoo.com/e/170313/uec10-q.html", "summary": "URANIUM ENERGY CORP Files SEC form 10-Q, Quarterly Report" }, { "title": "URANIUM ENERGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits", "publication_date": "2017-03-09 21:32:16 +0000", "url": "http://biz.yahoo.com/e/170309/uec8-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits" }, { "title": "The Fed's Dilemma Is Quite Obvious", "publication_date": "2017-02-14 15:48:00 +0000", "url": "http://realmoney.thestreet.com/articles/02/14/2017/feds-dilemma-quite-obvious?puc=yahoo&cm_ven=YAHOO", "summary": "The Fed's Dilemma Is Quite Obvious" }, { "title": "Why Investors Saw Double-Digit Gains in Denison Mines Corp. and Uranium Energy Corp. in January", "publication_date": "2017-02-08 17:42:03 +0000", "url": "http://www.fool.com/investing/2017/02/07/why-investors-saw-double-digit-gains-in-denison-mi.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2", "summary": "Why Investors Saw Double-Digit Gains in Denison Mines Corp. and Uranium Energy Corp. in January" }, { "title": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2017-02-07 21:44:17 +0000", "url": "http://biz.yahoo.com/e/170207/uec8-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "Why Investors Saw Double-Digit Gains in Denison Mines Corp. and Uranium Energy Corp. in January", "publication_date": "2017-02-07 17:19:52 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FCOcwzyK-wE/why-investors-saw-double-digit-gains-in-denison-mines-corp-and-uranium-energy-corp-in-january-cm744269", "summary": "What happened The big date for uranium miners Denison Mines Corp NYSEMKT DNN 160 and Uranium Energy Corp NYSEMKT UEC 160 was Nov 8 That was when the United States elected Donald Trump as president Since that point in time this pair of miners like uranium" }, { "title": "8:01 am Uranium Energy issues shareholder outlining 2017 for the company", "publication_date": "2017-02-07 13:01:00 +0000", "url": "http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#uec", "summary": "8:01 am Uranium Energy issues shareholder outlining 2017 for the company" }, { "title": "Uranium Energy Corp Issues Shareholder Letter and CEO Presentation", "publication_date": "2017-02-07 13:00:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-issues-shareholder-130000191.html", "summary": "[CNW Group] - Uranium Energy Corp Issues Shareholder Letter and CEO Presentation" }, { "title": "The Potential 'Rip Your Face Off' Uranium Rally", "publication_date": "2017-01-26 13:58:55 +0000", "url": "http://finance.yahoo.com/news/potential-rip-face-off-uranium-135855205.html", "summary": "The Potential 'Rip Your Face Off' Uranium Rally" }, { "title": "Here's Why Uranium Energy Corp. Jumped Nearly 14% Today", "publication_date": "2017-01-24 22:32:37 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9_GqBfJ8ZCM/heres-why-uranium-energy-corp-jumped-nearly-14-today-cm737650", "summary": "Image source Getty Images What happened Shares of exploration stage and mining company Uranium Energy Corp NYSEMKT UEC gained nearly 14 as of 3 01 p m EST today after President Trump made several moves that indicated his protectionist policy ideas on the campaign" }, { "title": "Here's Why Uranium Energy Corp. Jumped Nearly 14% Today", "publication_date": "2017-01-24 20:32:57 +0000", "url": "http://www.fool.com/investing/2017/01/24/heres-why-uranium-energy-corp-jumped-nearly-14-tod.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2", "summary": "Here's Why Uranium Energy Corp. Jumped Nearly 14% Today" }, { "title": "Precious Metals, Mining Lifting Markets", "publication_date": "2017-01-24 15:45:00 +0000", "url": "http://realmoney.thestreet.com/articles/01/24/2017/precious-metals-mining-lifting-markets?puc=yahoo&cm_ven=YAHOO", "summary": "Precious Metals, Mining Lifting Markets" }, { "title": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2017-01-20 21:06:05 +0000", "url": "http://biz.yahoo.com/e/170120/uec8-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "Uranium Energy Corp Closes $26 Million Public Offering", "publication_date": "2017-01-20 16:24:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-closes-26-162400266.html", "summary": "[PR Newswire] - \"UEC\" or the \"Company\") is pleased to announce that it has closed its previously announced public offering of 17,330,836 units of the Company (each, a \"Unit\"), at a price of $1.50 per Unit, for gross proceeds of approximately $26 million (the \"Offering\"). Each Unit is comprised of one common share of the Company (each, a \"Share\") and one-half of one common share purchase warrant (each whole warrant, a \"Warrant\"). Each Warrant will entitle its holder to acquire one common share (each, a \"Warrant Share\") at an exercise price of $2.00 per Warrant Share, exercisable six months following the closing of the Offering and expiring on the third anniversary following the closing of the Offering. The net proceeds of the Offering will be used to fund exploration and development expenditures at the Company's projects and for general corporate and working capital purposes." }, { "title": "URANIUM ENERGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement", "publication_date": "2017-01-17 15:07:43 +0000", "url": "http://biz.yahoo.com/e/170117/uec8-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement" }, { "title": "Uranium Energy Corp Increases Previously Announced Underwritten Public Offering to $26 Million", "publication_date": "2017-01-17 13:45:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-increases-previously-134500727.html", "summary": "[PR Newswire] - \"UEC\" or the \"Company\") is pleased to announce, that, that due to increased demand, the underwriters have agreed to purchase 17,330,836 units of the Company (the \"Units\") at a price of $1.50 per Unit, with each Unit consisting of one common share of the Company (each, a \"Share\") and one-half of one common share purchase warrant (each whole warrant, a \"Warrant\") for gross proceeds of approximately $26 million (the \"Offering\"). Each Warrant will entitle its holder to acquire one common share (each, a \"Warrant Share\") at an exercise price of $2.00 per Warrant Share and exercisable six months following the closing of the Offering and expiring on the third anniversary following the closing of the Offering. The Company anticipates that the net proceeds of the Offering will be used to fund exploration and development expenditures at the Company's projects and for general corporate and working capital purposes." }, { "title": "The Best Uranium Stock of 2016", "publication_date": "2017-01-14 16:25:38 +0000", "url": "http://www.fool.com/investing/2017/01/13/the-best-uranium-stock-of-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2", "summary": "The Best Uranium Stock of 2016" }, { "title": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2017-01-13 22:03:32 +0000", "url": "http://biz.yahoo.com/e/170113/uec8-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "Uranium Energy Corp. Announces Public Offering to Raise $10 Million", "publication_date": "2017-01-13 21:27:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-announces-public-212700460.html", "summary": "[PR Newswire] - \"UEC\" or the \"Company\") is pleased to announce a underwritten public offering (the \"Offering\") of units of the Company (the \"Units\") at a price of $1.50 per Unit, with each Unit being comprised of one common share of the Company (each, a \"Share\") and one‐half of one common share purchase warrant (each whole warrant, a \"Warrant\") to raise up to $10 Million. Each Warrant will entitle the holder to acquire one common share (each, a \"Warrant Share\") at a price per Warrant Share of $2.00 exercisable six months from and expiring on the third anniversary from closing. The Company anticipates that the net proceeds of the Offering will be used to fund exploration and development expenditures at the Company's projects and for general corporate and working capital purposes. Uranium Energy will host an investor conference call today, Friday, January 13, 2017, at 5:00PM EST, to discuss the proposed public offering." }, { "title": "The Best Uranium Stock of 2016", "publication_date": "2017-01-13 17:38:58 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WPCiQRVDm0A/the-best-uranium-stock-of-2016-cm733363", "summary": "It wasn t a good year for uranium in 2016 Investors had to suffer through continued commodity price weakness even though the long term backdrop for uranium and nuclear power remained relatively strong Indeed it took an iron stomach to buy a uranium miner like Cameco Corp" }, { "title": "Cameco and Uranium Energy Post Significant Gains as Uranium Prices Trending Upwards in 2017", "publication_date": "2017-01-12 14:30:00 +0000", "url": "http://finance.yahoo.com/news/cameco-uranium-energy-post-significant-143000167.html", "summary": "[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 12, 2017 / Uranium prices spiked Wednesday after the world's biggest supplier NAC Kazatomprom JSC, the national operator of Kazakhstan for import and export of uranium, ..." }, { "title": "Wednesday Sector Leaders: Metals & Mining, Gas Utilities", "publication_date": "2017-01-11 19:57:34 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0HAYeg1EehQ/wednesday-sector-leaders-metals-mining-gas-utilities-cm732372", "summary": "In trading on Wednesday metals amp mining shares were relative leaders up on the day by about 2 8 Leading the group were shares of Uranium Energy Corp UEC up about 14 9 and shares of Denison Mines Corp DNN up about 11 2 on the day Also showing relative strength are" }, { "title": "Energy Sector Update for 01/06/2017: UEC,URRE,BRN", "publication_date": "2017-01-06 21:08:34 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AFZFKaUTHCo/energy-sector-update-for-01062017-uecurrebrn-cm730582", "summary": "Top Energy StocksTop Energy Stocks XOM 0 05 XOM 0 05 CVX 0 17 CVX 0 17 COP 0 08 COP 0 08 SLB 1 59 SLB 1 59 OXY 0 99 OXY 0 99 Energy stocks were ending mixed this afternoon with the NYSE Energy Sector Index slipping about 0 1 while shares of energy companies in the S amp P 500" }, { "title": "Uranium Energy Corp Forecast and Sector Outlook", "publication_date": "2017-01-04 13:00:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-forecast-sector-130000927.html", "summary": "[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 4, 2017 / Traders News Source, an equity research firm specializing in small and micro-cap securities, is looking at recent events with Uranium Energy Corp (NYSE MKT: ..." }, { "title": "Everything Investors Need To Know About The Nuclear Energy Industry", "publication_date": "2017-01-03 23:01:11 +0000", "url": "http://finance.yahoo.com/news/everything-investors-know-nuclear-energy-230111745.html", "summary": "Everything Investors Need To Know About The Nuclear Energy Industry" }, { "title": "Wednesday's ETF with Unusual Volume: URA", "publication_date": "2016-12-28 19:56:59 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WK75_9VRzgY/wednesdays-etf-with-unusual-volume-ura-cm727101", "summary": "The Uranium ETF URA is seeing unusually high volume in afternoon trading Wednesday with over 408 000 shares traded versus three month average volume of about 135 000 Shares of URA were down about 6 9 on the day Components of that ETF with the highest volume on Wednesday were" }, { "title": "Uranium stocks find spotlight with Trump's nuclear comments", "publication_date": "2016-12-23 21:56:30 +0000", "url": "http://finance.yahoo.com/news/uranium-stocks-spotlight-trumps-nuclear-215630484.html", "summary": "[Reuters] - Donald Trump's call for an expansion of the United States' nuclear capabilities has shone a spotlight on a group of uranium stocks that has been battered over the past six years but have seen some new life since his presidential election victory. A clutch of uranium companies including Uranium Energy Corp and Ur-Energy Inc trade at around $1 a share or even less and have market values of less than $400 million. During the presidential campaign, Trump said the U.S. nuclear arsenal should be modernized and suggested Japan and South Korea could acquire nuclear weapons." }, { "title": "Trump's nuclear remarks test bid to improve Russia ties", "publication_date": "2016-12-23 20:50:10 +0000", "url": "http://finance.yahoo.com/news/trumps-nuclear-remarks-test-bid-205010353.html", "summary": "[Reuters] - WEST PALM BEACH, Fla./MOSCOW, Dec 23 (Reuters) - U.S. President-elect Donald Trump upped the stakes on Friday in a back-and-forth exchange with President Vladimir Putin over nuclear weapons that tested the Republican's promises to improve relations with Russia. Offering a glimpse of how he might conduct diplomacy after taking office on Jan. 20, Trump reportedly welcomed a nuclear arms race with Russia and China and boasted that the United States would win it. MSNBC host Mika Brzezinski said Trump told her in an off-air phone call: \"Let it be an arms race." }, { "title": "Trump 'arms race' comment sows more doubt on nuclear policy", "publication_date": "2016-12-23 17:22:13 +0000", "url": "http://finance.yahoo.com/news/trump-nuclear-weapons-tweet-let-130437554.html", "summary": "[Reuters] - U.S. President-elect Donald Trump sowed more doubt about his position on nuclear proliferation on Friday, reportedly welcoming an arms race even as his spokesman insisted that an atomic weapons build-up was not likely to happen. On Friday, he had an off-air phone conversation about the tweet with MSNBC TV host Mika Brzezinski, who said Trump told her: \"Let it be an arms race." }, { "title": "Trump tweets about nuclear weapons, raising questions and fears", "publication_date": "2016-12-22 23:12:04 +0000", "url": "http://finance.yahoo.com/news/trump-calls-expanded-u-nuclear-203308329.html", "summary": "[Reuters] - PALM BEACH, Fla./WASHINGTON, Dec 22 (Reuters) - P resident-elect Donald Trump called for an expansion of the United States' nuclear capabilities on Thursday, in a tweet that alarmed nonproliferation experts who said that a boost to the U.S. arsenal could fuel global tensions. In his Twitter post, Trump said, \"The United States must greatly strengthen and expand its nuclear capability until such time as the world comes to its senses regarding nukes,\" but gave no further details." }, { "title": "UPDATE 1-Trump calls for expanded U.S. nuclear weapons capability", "publication_date": "2016-12-22 19:53:00 +0000", "url": "http://finance.yahoo.com/news/trump-calls-expanded-u-nuclear-175836248.html", "summary": "[Reuters] - PALM BEACH, Fla./WASHINGTON, Dec 22 (Reuters) - U.S. President-elect Donald Trump called on Thursday for the country to expand its nuclear weapons capabilities until the world \"comes to its senses\" - a signal he may support costly efforts to modernize the aging U.S. nuclear arsenal. \"The United States must greatly strengthen and expand its nuclear capability until such time as the world comes to its senses regarding nukes,\" Trump said in a post on Twitter. Trump, who is at his Florida resort for the Christmas holiday, gave no details about what prompted his tweet." }, { "title": "URANIUM ENERGY CORP Financials", "publication_date": "2016-12-15 18:04:07 +0000", "url": "http://finance.yahoo.com/q/is?s=uec", "summary": "URANIUM ENERGY CORP Financials" }, { "title": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2016-12-13 21:37:04 +0000", "url": "http://biz.yahoo.com/e/161213/uec8-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "How Trillium Therapeutics Inc. (TRIL) Stacks Up Against Its Peers?", "publication_date": "2016-12-13 14:51:46 +0000", "url": "http://www.insidermonkey.com/blog/how-trillium-therapeutics-inc-tril-stacks-up-against-its-peers-507967/", "summary": "How Trillium Therapeutics Inc. (TRIL) Stacks Up Against Its Peers?" }, { "title": "Uranium Energy Corp Receives Final Mine Permit for Its Burke Hollow ISR Project in South Texas", "publication_date": "2016-12-13 12:00:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-receives-final-120000345.html", "summary": "[CNW Group] - Uranium Energy Corp Receives Final Mine Permit for Its Burke Hollow ISR Project in South Texas" }, { "title": "Uranium Energy Corp Receives Final Mine Permit for Its Burke Hollow ISR Project in South Texas", "publication_date": "2016-12-13 12:00:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-receives-final-120000862.html", "summary": "[PR Newswire] - Amir Adnani, President & CEO, stated: \"We are very pleased with the progress made at Burke Hollow over the past four years. The Mine Area Permit authorizes over 11,000 acres for mining multiple production sands within two large confirmed production areas discovered to date. TCEQ has earlier issued two final Class 1 disposal well permits for the Burke Hollow project." }, { "title": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2016-12-12 21:46:10 +0000", "url": "http://biz.yahoo.com/e/161212/uec8-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "Uranium Energy reports 1Q loss", "publication_date": "2016-12-12 11:12:19 +0000", "url": "http://sg.finance.yahoo.com/news/uranium-energy-reports-1q-loss-111219708.html", "summary": "Uranium Energy reports 1Q loss" }, { "title": "Uranium Energy Corp Files Fiscal 2017 Q1 Report", "publication_date": "2016-12-12 11:05:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-files-fiscal-110500199.html", "summary": "[PR Newswire] - CORPUS CHRISTI, TX, Dec. 12, 2016 /PRNewswire/ - Uranium Energy Corp (NYSE MKT: UEC, the \"Company\" or \"UEC\") is pleased to report, in accordance with NYSE MKT requirements, the filing of the Company's quarterly report on Form 10-Q for the three months ended October 31, 2016 with the U.S. Securities and Exchange Commission (the \"SEC\"). This Form 10-Q filing, which includes the Company's condensed consolidated financial statements, related notes thereto and management's discussion and analysis, is available for viewing on the SEC's website at http://www.sec.gov/edgar.shtml or on the Company's website at www.uraniumenergy.com." }, { "title": "Uranium Energy Corp Files Fiscal 2017 Q1 Report", "publication_date": "2016-12-12 11:05:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-files-fiscal-110500057.html", "summary": "[CNW Group] - Uranium Energy Corp Files Fiscal 2017 Q1 Report" }, { "title": "URANIUM ENERGY CORP Files SEC form 10-Q, Quarterly Report", "publication_date": "2016-12-12 11:03:40 +0000", "url": "http://biz.yahoo.com/e/161212/uec10-q.html", "summary": "URANIUM ENERGY CORP Files SEC form 10-Q, Quarterly Report" }, { "title": "Five Uranium Stocks to Buy According to Hedge Funds", "publication_date": "2016-12-04 00:55:49 +0000", "url": "http://www.insidermonkey.com/blog/five-uranium-stocks-to-buy-according-to-hedge-funds-2-493386/", "summary": "[at Insider Monkey] - Although uranium prices have crashed since the tragic Fukushima disaster, some analysts think a revival in the uranium sector could be impending amid an increasing appetite for alternative energy sources around the world. Several uranium analysts such as David Talbot of Dundee Capital Markets and Raymond Goldie of Salman Partners predict that uranium prices are set […]" }, { "title": "Uranium Energy Corp. :UEC-US: Earnings Analysis: Q4, 2016 By the Numbers : October 28, 2016", "publication_date": "2016-10-28 16:37:20 +0000", "url": "http://www.capitalcube.com/blog/index.php/uranium-energy-corp-uec-us-earnings-analysis-q4-2016-by-the-numbers-october-28-2016/", "summary": "Uranium Energy Corp. :UEC-US: Earnings Analysis: Q4, 2016 By the Numbers : October 28, 2016" }, { "title": "Uranium Energy Reports No Annual Profit (UEC)", "publication_date": "2016-10-17 16:25:00 +0000", "url": "http://www.investopedia.com/news/uranium-energy-reports-no-annual-profit-uec/?partner=YahooSA", "summary": "Uranium Energy Reports No Annual Profit (UEC)" }, { "title": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2016-10-14 20:16:41 +0000", "url": "http://biz.yahoo.com/e/161014/uec8-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "Uranium Energy reports 4Q loss", "publication_date": "2016-10-14 12:11:36 +0000", "url": "http://sg.finance.yahoo.com/news/uranium-energy-reports-4q-loss-121136614.html", "summary": "Uranium Energy reports 4Q loss" }, { "title": "Uranium Energy Corp Files Fiscal 2016 Annual Report", "publication_date": "2016-10-14 10:30:06 +0000", "url": "http://www.publicnow.com/view/419D05A6BE929907343A5E35F3676F42536E43C8", "summary": "[at noodls] - Corpus Christi, TX, October 14, 2016 - Uranium Energy Corp (NYSE MKT: UEC, the 'Company' or 'UEC') is pleased to report, in accordance with NYSE MKT requirements, the filing of the Company's annual report ..." }, { "title": "URANIUM ENERGY CORP Files SEC form 10-K, Annual Report", "publication_date": "2016-10-14 10:07:33 +0000", "url": "http://biz.yahoo.com/e/161014/uec10-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 10-K, Annual Report" }, { "title": "Uranium Energy Corp Files Fiscal 2016 Annual Report", "publication_date": "2016-10-14 10:05:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-files-fiscal-100500519.html", "summary": "[CNW Group] - Uranium Energy Corp Files Fiscal 2016 Annual Report" }, { "title": "Uranium Energy on Verge of Oversold (UEC)", "publication_date": "2016-10-12 01:43:00 +0000", "url": "http://www.investopedia.com/news/uranium-energy-verge-oversold-uec/?partner=YahooSA", "summary": "Uranium Energy on Verge of Oversold (UEC)" }, { "title": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2016-09-29 21:05:01 +0000", "url": "http://biz.yahoo.com/e/160929/uec8-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "UEC Gains after Court Dismisses Lawsuit (UEC)", "publication_date": "2016-09-29 16:37:00 +0000", "url": "http://www.investopedia.com/news/uec-gains-after-court-dismisses-lawsuit-uec/?partner=YahooSA", "summary": "UEC Gains after Court Dismisses Lawsuit (UEC)" }, { "title": "Uranium Energy Corp Announces Final Dismissal of Previously Disclosed Lawsuit", "publication_date": "2016-09-29 13:10:10 +0000", "url": "http://www.publicnow.com/view/2339BEF57480CED347AA4925F8C0836BD11225B0", "summary": "[at noodls] - September 29, 2016, Corpus Christi, Texas - Uranium Energy Corp (NYSE MKT: UEC, the 'Company' or 'UEC') is pleased to report that the United States District Court for the Southern District of Texas has ..." }, { "title": "Why Uranium Won’t Recover Anytime Soon (CCJ, UEC)", "publication_date": "2016-09-19 20:26:00 +0000", "url": "http://www.investopedia.com/news/why-uranium-wont-recover-anytime-soon-ccj-uec/?partner=YahooSA", "summary": "Why Uranium Won’t Recover Anytime Soon (CCJ, UEC)" }, { "title": "URANIUM ENERGY CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events", "publication_date": "2016-07-29 20:15:20 +0000", "url": "http://biz.yahoo.com/e/160729/uec8-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events" }, { "title": "Uranium Energy Corp Announces Results of Annual General Meeting", "publication_date": "2016-07-28 21:48:05 +0000", "url": "http://www.publicnow.com/view/8C5D9A725ED599359AD8CF7F89963B23D13ED8D9", "summary": "[at noodls] - July 28, 2016, Corpus Christi, Texas - Uranium Energy Corp (NYSE MKT: UEC, the 'Company' or 'UEC') is pleased to announce that, in conjunction with the holding of the Company's recent annual general meeting ..." }, { "title": "Wednesday Sector Leaders: Precious Metals, Metals & Mining Stocks", "publication_date": "2016-06-29 18:47:40 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NK8L7LKdIR4/wednesday-sector-leaders-precious-metals-metals-mining-stocks-cm642816", "summary": "In trading on Wednesday, precious metals shares were relative leaders, up on the day by about 4.2%. Leading the group were shares of Exeter Resources ( XRA ), up about 21.1% and shares of Alexco Resource ( AXU )" }, { "title": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2016-06-09 21:25:41 +0000", "url": "http://biz.yahoo.com/e/160609/uec8-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "Uranium Energy reports 3Q loss", "publication_date": "2016-06-09 12:12:37 +0000", "url": "http://sg.finance.yahoo.com/news/uranium-energy-reports-3q-loss-121237717.html", "summary": "Uranium Energy reports 3Q loss" }, { "title": "Uranium Energy Corp Files Fiscal 2016 Q3 Report", "publication_date": "2016-06-09 10:39:03 +0000", "url": "http://www.publicnow.com/view/339A8F81045E3C69A6B5ED1200F12F91E0C136C4", "summary": "[at noodls] - Corpus Christi, TX, June 9, 2016 - Uranium Energy Corp (NYSE MKT: UEC, the 'Company' or 'UEC') is pleased to report, in accordance with NYSE MKT requirements, the filing of the Company's quarterly report ..." }, { "title": "URANIUM ENERGY CORP Files SEC form 10-Q, Quarterly Report", "publication_date": "2016-06-09 10:10:40 +0000", "url": "http://biz.yahoo.com/e/160609/uec10-q.html", "summary": "URANIUM ENERGY CORP Files SEC form 10-Q, Quarterly Report" }, { "title": "World’s Worst Commodity Forecast to Rally as Uranium Miners Cut", "publication_date": "2016-06-07 23:00:00 +0000", "url": "http://www.bloomberg.com/news/articles/2016-06-07/world-s-worst-commodity-forecast-to-rally-as-uranium-miners-cut?cmpid=yhoo.headline", "summary": "World’s Worst Commodity Forecast to Rally as Uranium Miners Cut" }, { "title": "5 Stocks That Are Popping Today: AMD, Globalstar, Uranium Energy, More", "publication_date": "2016-06-07 15:24:27 +0000", "url": "http://www.insidermonkey.com/blog/5-stocks-that-are-popping-today-amd-globalstar-uranium-energy-more-458349/", "summary": "5 Stocks That Are Popping Today: AMD, Globalstar, Uranium Energy, More" }, { "title": "Monday Sector Leaders: Oil & Gas Equipment & Services, Metals & Mining Stocks", "publication_date": "2016-06-06 20:04:42 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o9bQZKVRxwU/monday-sector-leaders-oil-gas-equipment-services-metals-mining-stocks-cm631139", "summary": "In trading on Monday, oil & gas equipment & services shares were relative leaders, up on the day by about 4%. Leading the group were shares of C&J Energy Services ( CJES ), up about 20.5% and shares of" }, { "title": "Friday Sector Leaders: Precious Metals, Metals & Mining Stocks", "publication_date": "2016-06-03 19:02:07 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RwMqqAN8xMo/friday-sector-leaders-precious-metals-metals-mining-stocks-cm630306", "summary": "In trading on Friday, precious metals shares were relative leaders, up on the day by about 8.2%. Leading the group were shares of Exeter Resources Corporation ( XRA ), up about 16% and shares of International Tower Hill Mines" }, { "title": "Five Uranium Stocks to Buy According to Hedge Funds", "publication_date": "2016-03-21 19:46:16 +0000", "url": "http://www.insidermonkey.com/blog/five-uranium-stocks-to-buy-according-to-hedge-funds-438762/", "summary": "[at Insider Monkey] - With a surge in solar and wind powered energy, one would expect that demand for nuclear reactors to produce electricity. Still wary of everything nuclear following the Fukushima disaster, countries like Germany and Japan have stepped up efforts to reduce their dependence on nuclear-powered energy. This does not apply to China and India, whose appetite […]" }, { "title": "Uranium Energy reports 2Q loss", "publication_date": "2016-03-11 15:35:41 +0000", "url": "http://sg.finance.yahoo.com/news/uranium-energy-reports-2q-loss-153541165.html", "summary": "Uranium Energy reports 2Q loss" }, { "title": "Uranium Energy Corp Closes $10.51 Million Financing", "publication_date": "2016-03-11 14:00:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-closes-10-140000539.html", "summary": "[CNW Group] - Uranium Energy Corp Closes $10.51 Million Financing" }, { "title": "URANIUM ENERGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob", "publication_date": "2016-03-10 22:32:03 +0000", "url": "http://biz.yahoo.com/e/160310/uec8-k.html", "summary": "URANIUM ENERGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob" }, { "title": "Uranium Energy Corp Announces a $10.5 Million Financing", "publication_date": "2016-03-07 14:28:00 +0000", "url": "http://finance.yahoo.com/news/uranium-energy-corp-announces-10-142800982.html", "summary": "[PR Newswire] - The Company is offering and selling the Units pursuant to a Securities Purchase Agreement dated March 6, 2016. The Company anticipates that the net proceeds from the Offering will be used for general corporate and working capital purposes. The Units are being offered by the Company pursuant to a prospectus supplement to the Company's effective shelf registration statement on Form S-3 (File No. ‪333-193104) previously filed with the United States Securities and Exchange Commission (the \"SEC\"). A prospectus supplement relating to the Offering will be filed by the Company with the SEC. Copies of the prospectus supplement and accompanying base prospectus relating to the Offering may be obtained from the SEC's website at http://www.sec.gov, by sending an email request to Rodman & Renshaw a unit of H.C. Wainwright & Co., LLC at placements@hcwco.com, by calling Dundee Securities Ltd. at ‪416 849 7887 or by contacting the Company at Suite 800N, 500 North Shoreline Boulevard, Corpus Christi, Texas 78401." }, { "title": "Uranium Energy Corp Advances Burke Hollow ISR Project in South Texas", "publication_date": "2015-12-09 12:30:22 +0000", "url": "http://www.noodls.com/view/A364DA3A91CE41D3297E3C11670FB139F933672B", "summary": "[at noodls] - Successful completion of a 25,000-foot drill program at Burke Hollow results in the extension of the Eastern Lower B trend from 1.7 miles to approximately 3.7 miles The Eastern Lower B trend will be the ..." }, { "title": "Uranium Energy Corp Reports Fiscal 2016 Q1 Results", "publication_date": "2015-12-08 21:46:30 +0000", "url": "http://www.noodls.com/view/889BB24B96AA55FC07A919A5CAD597DF1BE77398", "summary": "[at noodls] - Corpus Christi, TX, December 8, 2015 - Uranium Energy Corp (NYSE MKT: UEC, the 'Company' or 'UEC') is pleased to report, in accordance with NYSE MKT requirements, the filing of the Company's quarterly ..." }, { "title": "Uranium Energy reports 1Q loss", "publication_date": "2015-12-08 21:31:21 +0000", "url": "http://sg.finance.yahoo.com/news/uranium-energy-reports-1q-loss-213121519.html", "summary": "Uranium Energy reports 1Q loss" }, { "title": "Uranium Energy Corp Appoints Interim CFO", "publication_date": "2015-10-30 13:08:15 +0000", "url": "http://www.noodls.com/view/EFB5E05F3B7294F0CF6000BFE2C9EFF301D02B99", "summary": "[at noodls] - Corpus Christi, TX, October 30, 2015 - Uranium Energy Corp (NYSE MKT: UEC, 'UEC' or the 'Company') is pleased to announce the appointment of Pat Obara, the Company's current Vice President, Administration, ..." }, { "title": "Former U.S. Energy Secretary Spencer Abraham Joins the Board of Directors of Uranium Energy Corp as Executive Chairman", "publication_date": "2015-10-15 13:02:04 +0000", "url": "http://www.noodls.com/view/03F127CF36808C4A848952DBD3B272D1F5F38ED0", "summary": "[at noodls] - Corpus Christi, TX, October 15, 2015 - Uranium Energy Corp (NYSE MKT: UEC, the 'Company') is pleased to announce the appointment of former United States Energy Secretary Spencer Abraham as Executive Chairman ..." }, { "title": "Uranium Energy Corp Reports 2015 Fiscal Year Results", "publication_date": "2015-10-14 12:31:21 +0000", "url": "http://www.noodls.com/view/EAF96E96F0F580A5F957BD8A15E1152CA32DFB2B", "summary": "[at noodls] - Corpus Christi, TX, October 14, 2015 - Uranium Energy Corp (NYSE MKT: UEC, the 'Company' or 'UEC') is pleased to report, in accordance with NYSE MKT requirements, the filing of the Company's annual report ..." }, { "title": "Uranium Energy reports 4Q loss", "publication_date": "2015-10-14 10:35:49 +0000", "url": "http://sg.finance.yahoo.com/news/uranium-energy-reports-4q-loss-103549007.html", "summary": "Uranium Energy reports 4Q loss" }, { "title": "Uranium Energy Corp and the International Atomic Energy Agency Advance Uranium Cooperation with Paraguay’s Government", "publication_date": "2015-09-09 12:55:23 +0000", "url": "http://www.noodls.com/view/0197AF1C30A76E0E2C686C8BC4D6BFA12536D7CC", "summary": "[at noodls] - September 9, 2015 Corpus Christi, TX, September 9, 2015 - Uranium Energy Corp (NYSE MKT: UEC, the 'Company' or 'UEC') is pleased to announce that the International Atomic Energy Agency ('IAEA') recently ..." }, { "title": "Uranium Energy Corp to Present at the 17th Annual Rodman & Renshaw Global Investment Conference in New York City September 8 – 10, 2015", "publication_date": "2015-09-01 20:43:03 +0000", "url": "http://www.noodls.com/view/E23DB16E40249731E8EC8DC3B6C7E4154D23ED96", "summary": "[at noodls] - September 1, 2015 Corpus Christi, TX, September 1, 2015 - Uranium Energy Corp (NYSE MKT: UEC, the 'Company' or 'UEC') is pleased to announce the Company will be featured as a presenting company at the ..." }, { "title": "Tuesday Sector Leaders: Precious Metals, Metals & Mining Stocks", "publication_date": "2015-07-21 18:27:26 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sD_nE0J2kB0/tuesday-sector-leaders-precious-metals-metals-mining-stocks-cm498965", "summary": "In trading on Tuesday, precious metals shares were relative leaders, up on the day by about 2.6%. Leading the group were shares of Gold Resource ( GORO ), up about 8.5% and shares of Harmony Gold Mining Company (" }, { "title": "Wednesday 7/15 Insider Buying Report: UEC", "publication_date": "2015-07-15 16:29:56 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1TUZAfqlzqw/wednesday-715-insider-buying-report-uec-cm496666", "summary": "As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy they expect to make money. So let's look at one noteworthy recent insider buy. On Friday, Director" }, { "title": "Monday Sector Laggards: Oil & Gas Exploration & Production, Metals & Mining Stocks", "publication_date": "2015-07-06 16:29:08 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QhfI9KcnES0/monday-sector-laggards-oil-gas-exploration-production-metals-mining-stocks-cm493375", "summary": "In trading on Monday, oil & gas exploration & production shares were relative laggards, down on the day by about 2.3%. Helping drag down the group were shares of Harvest Natural Resources ( HNR ), down about 10.1% and" }, { "title": "Thursday Sector Laggards: Shipping, Metals & Mining Stocks", "publication_date": "2015-06-25 16:29:31 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/459uQts6D6s/thursday-sector-laggards-shipping-metals-mining-stocks-cm490744", "summary": "In trading on Thursday, shipping shares were relative laggards, down on the day by about 1.4%. Helping drag down the group were shares of Diana Containerships ( DCIX ), off about 6.5% and shares of Frontline ( FRO )" }, { "title": "Uranium Energy, Energy Fuels Soar on Russell 3000 Addition - Analyst Blog", "publication_date": "2015-06-23 23:30:53 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kwXtaLm1KjQ/uranium-energy-energy-fuels-soar-on-russell-3000-addition-analyst-blog-cm489991", "summary": "Shares of uranium mining companies Uranium Energy UEC and Energy Fuels UUUU flew higher yesterday on news that they will be inducted into the Russell 3000 Index at the conclusion of the annual reconstitution of the Russell indexes on" }, { "title": "Energy Sector Update for 06/22/2015: UEC,WMB,ETE,MPET", "publication_date": "2015-06-22 20:08:04 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6UYBbDUqlvI/energy-sector-update-for-06222015-uecwmbetempet-cm489451", "summary": "Top Energy Stocks XOM 0.05% CVX +0.77% COP +0.49% SLB +0.47% OXY +0.78% Energy stocks were sharply higher Monday with the NYSE Energy Sector Index rising almost 1.3% while shares of energy companies in the S&P 500 were up" }, { "title": "Friday Sector Laggards: Advertising, Metals & Mining Stocks", "publication_date": "2015-06-19 15:30:04 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RO-a9dcR4xs/friday-sector-laggards-advertising-metals-mining-stocks-cm488749", "summary": "In trading on Friday, advertising shares were relative laggards, down on the day by about 0.9%. Helping drag down the group were shares of Sizmek ( SZMK ), down about 4.1% and shares of Marchex ( MCHX ) down" }, { "title": "Uranium Energy Corp. (UEC) in Focus, Stock Jumps 7.4% - Tale of the Tape", "publication_date": "2015-05-29 15:00:45 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GFm6uQM2VXA/uranium-energy-corp-uec-in-focus-stock-jumps-74-tale-of-the-tape-cm481627", "summary": "Uranium Energy Corp. ( UEC ) was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume too with far more shares changing hands than in" }, { "title": "Uranium Energy (UEC) Shares March Higher, Can It Continue? - Tale of the Tape", "publication_date": "2015-05-13 17:01:46 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z8pTQExDKTw/uranium-energy-uec-shares-march-higher-can-it-continue-tale-of-the-tape-cm476493", "summary": "As of late, it has definitely been a great time to be an investor in Uranium Energy Corp. ( UEC ) . The stock has moved higher by 70.8% in the past month, while it is also above its" }, { "title": "Thursday's ETF with Unusual Volume: URA", "publication_date": "2015-04-23 19:21:11 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QEWjUXpHjRA/thursdays-etf-with-unusual-volume-ura-cm468743", "summary": "The Uranium ETF ( URA ) is seeing unusually high volume in afternoon trading Thursday, with over 663,000 shares traded versus three month average volume of about 151,000. Shares of URA were up about 4.5% on the day. Components" }, { "title": "Thursday Sector Laggards: Metals & Mining, Computer Peripherals", "publication_date": "2015-03-12 19:30:20 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m_Vibec-s2Y/thursday-sector-laggards-metals-mining-computer-peripherals-cm454279", "summary": "In trading on Thursday, metals & mining shares were relative laggards, down on the day by about 1.4%. Helping drag down the group were shares of Molycorp ( MCP ), off about 15.3% and shares of Uranium Energy Corporation" }, { "title": "Wednesday Sector Laggards: Metals & Mining, Non-Precious Metals & Non-Metallic Mining Stocks", "publication_date": "2015-01-14 22:49:46 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FHonmWv41uo/wednesday-sector-laggards-metals-mining-non-precious-metals-non-metallic-mining-stocks-cm432909", "summary": "In trading on Wednesday, metals & mining shares were relative laggards, down on the day by about 3.7%. Helping drag down the group were shares of Uranium Energy ( UEC ), down about 10.7% and shares of Teck Resources" } ], "result_count": 93, "page_size": 250, "current_page": 1, "total_pages": 1, "api_call_credits": 1 }, "chart":[{"values":[ {"x":"1489411800","y":"1.3"},{"x":"1489412100","y":"1.2852000000000001"},{"x":"1489412400","y":"1.29"},{"x":"1489412700","y":"1.3"},{"x":"1489413000","y":"1.294"},{"x":"1489413300","y":"1.29"},{"x":"1489413600","y":"1.3"},{"x":"1489413900","y":"1.296"},{"x":"1489414200","y":"1.3193"},{"x":"1489414500","y":"1.32"},{"x":"1489414800","y":"1.3065"},{"x":"1489415100","y":"1.307"},{"x":"1489415400","y":"1.305"},{"x":"1489415700","y":"1.335"},{"x":"1489416000","y":"1.34"},{"x":"1489416300","y":"1.3361"},{"x":"1489416600","y":"1.33"},{"x":"1489416900","y":"1.33"},{"x":"1489417200","y":"1.335"},{"x":"1489417500","y":"1.34"},{"x":"1489417800","y":"1.34"},{"x":"1489418100","y":"1.335"},{"x":"1489418400","y":"1.335"},{"x":"1489418700","y":"1.33"},{"x":"1489419000","y":"1.3399"},{"x":"1489419300","y":"1.335"},{"x":"1489419600","y":"1.33"},{"x":"1489419900","y":"1.33"},{"x":"1489420200","y":"1.34"},{"x":"1489420500","y":"1.33"},{"x":"1489420800","y":"1.34"},{"x":"1489421100","y":"1.34"},{"x":"1489421400","y":"1.34"},{"x":"1489421700","y":"1.34"},{"x":"1489422000","y":"1.335"},{"x":"1489422300","y":"1.335"},{"x":"1489422600","y":"1.3201"},{"x":"1489422900","y":"1.34"},{"x":"1489423200","y":"1.34"},{"x":"1489423500","y":"1.335"},{"x":"1489423800","y":"1.335"},{"x":"1489424100","y":"1.33"},{"x":"1489424400","y":"1.34"},{"x":"1489424700","y":"1.345"},{"x":"1489425000","y":"1.35"},{"x":"1489425300","y":"1.35"},{"x":"1489425600","y":"1.349"},{"x":"1489425900","y":"1.33"},{"x":"1489426200","y":"1.33"},{"x":"1489426500","y":"1.34"},{"x":"1489426800","y":"1.34"},{"x":"1489427100","y":"1.34"},{"x":"1489427400","y":"1.345"},{"x":"1489427700","y":"1.35"},{"x":"1489428000","y":"1.345"},{"x":"1489428300","y":"1.33"},{"x":"1489428600","y":"1.33"},{"x":"1489428900","y":"1.335"},{"x":"1489429200","y":"1.33"},{"x":"1489429500","y":"1.33"},{"x":"1489429800","y":"1.335"},{"x":"1489430100","y":"1.34"},{"x":"1489430400","y":"1.34"},{"x":"1489430700","y":"1.35"},{"x":"1489431000","y":"1.35"},{"x":"1489431300","y":"1.345"},{"x":"1489431600","y":"1.345"},{"x":"1489431900","y":"1.34"},{"x":"1489432200","y":"1.34"},{"x":"1489432500","y":"1.345"},{"x":"1489432800","y":"1.34"},{"x":"1489433100","y":"1.3431"},{"x":"1489433400","y":"1.34"},{"x":"1489433700","y":"1.34"},{"x":"1489434000","y":"1.34"},{"x":"1489434300","y":"1.34"},{"x":"1489434600","y":"1.33"},{"x":"1489434900","y":"1.33"},{"x":"1489435200","y":"1.33"} ], "color":"#03a9f4"}]},
{"id":"6","list":"Calendar Movers","symbol": "WMIH","name": "WMIH Corp","price": 1.15,"dollarChange": 0.05,"percentChange": 4.55,"time":4.0,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/WMIH-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/WMIH-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/WMIH-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/WMIH-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/WMIH-1yr.php","open": 1.1,"high": 1.2,"low":1.075,"volume": 662019,"avgVol": 550821.687500,"sharesShort": 6184359,"shortPercent": 3.028638,"marketCap": 278614080,"float": 204196047,"headlines":{ "data": [ { "title": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2017-03-09 21:16:57 +0000", "url": "http://biz.yahoo.com/e/170309/wmih8-k.html", "summary": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2017-02-08 21:16:52 +0000", "url": "http://biz.yahoo.com/e/170208/wmih8-k.html", "summary": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "WMIH Corp. breached its 50 day moving average in a Bullish Manner : WMIH-US : February 1, 2017", "publication_date": "2017-02-01 12:13:17 +0000", "url": "http://www.capitalcube.com/blog/index.php/wmih-corp-breached-its-50-day-moving-average-in-a-bullish-manner-wmih-us-february-1-2017/", "summary": "WMIH Corp. breached its 50 day moving average in a Bullish Manner : WMIH-US : February 1, 2017" }, { "title": "WMIH CORP. Files SEC form 8-K, Change of Servicer or Trustee", "publication_date": "2017-01-11 21:18:10 +0000", "url": "http://biz.yahoo.com/e/170111/wmih8-k.html", "summary": "WMIH CORP. Files SEC form 8-K, Change of Servicer or Trustee" }, { "title": "[$$] After Retiring From Washington Mutual, Louis Pepper Couldn’t Let Go", "publication_date": "2017-01-07 04:30:05 +0000", "url": "http://www.wsj.com/articles/after-retiring-from-washington-mutual-louis-pepper-couldnt-let-go-1483714802?ru=yahoo?mod=yahoo_itp", "summary": "[$$] After Retiring From Washington Mutual, Louis Pepper Couldn’t Let Go" }, { "title": "[$$] After Retiring From Washington Mutual, Louis Pepper Couldn't Let Go", "publication_date": "2017-01-06 15:00:12 +0000", "url": "http://www.wsj.com/articles/after-retiring-from-washington-mutual-louis-pepper-couldnt-let-go-1483714802?mod=yahoo_hs", "summary": "[$$] After Retiring From Washington Mutual, Louis Pepper Couldn't Let Go" }, { "title": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2017-01-05 21:17:27 +0000", "url": "http://biz.yahoo.com/e/170105/wmih8-k.html", "summary": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "WMIH Corp.: Strong price momentum but will it sustain?", "publication_date": "2017-01-02 20:20:34 +0000", "url": "http://www.capitalcube.com/blog/index.php/wmih-corp-strong-price-momentum-but-will-it-sustain/", "summary": "WMIH Corp.: Strong price momentum but will it sustain?" }, { "title": "Is El Pollo LoCo Holdings Inc (LOCO) A Good Stock To Buy?", "publication_date": "2016-12-13 01:30:25 +0000", "url": "http://www.insidermonkey.com/blog/is-el-pollo-loco-holdings-inc-loco-a-good-stock-to-buy-507232/", "summary": "Is El Pollo LoCo Holdings Inc (LOCO) A Good Stock To Buy?" }, { "title": "Is MYR Group Inc (MYRG) A Good Investment?", "publication_date": "2016-12-08 21:29:39 +0000", "url": "http://www.insidermonkey.com/blog/is-myr-group-inc-myrg-a-good-investment-501954/", "summary": "Is MYR Group Inc (MYRG) A Good Investment?" }, { "title": "Is Sunedison Semiconductor Ltd (SEMI) A Good Stock To Buy?", "publication_date": "2016-12-08 08:47:36 +0000", "url": "http://www.insidermonkey.com/blog/is-sunedison-semiconductor-ltd-semi-a-good-stock-to-buy-501005/", "summary": "Is Sunedison Semiconductor Ltd (SEMI) A Good Stock To Buy?" }, { "title": "Do Hedge Funds Love WMIH Corp. (WMIH)?", "publication_date": "2016-12-07 21:41:51 +0000", "url": "http://www.insidermonkey.com/blog/do-hedge-funds-love-wmih-corp-wmih-500713/", "summary": "Do Hedge Funds Love WMIH Corp. (WMIH)?" }, { "title": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2016-12-06 21:16:49 +0000", "url": "http://biz.yahoo.com/e/161206/wmih8-k.html", "summary": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "Mnuchin Made Millions From Financial Crisis -2-", "publication_date": "2016-12-01 08:05:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pHEN4B159kY/mnuchin-made-millions-from-financial-crisis-2-20161201-00436", "summary": "Mnuchin Made Millions From Financial Crisis -2-" }, { "title": "Mnuchin Made Millions From Financial Crisis", "publication_date": "2016-12-01 08:05:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wNGbM3PSF0E/mnuchin-made-millions-from-financial-crisis-20161201-00435", "summary": "Mnuchin Made Millions From Financial Crisis" }, { "title": "ETFs with exposure to WMIH Corp. : November 30, 2016", "publication_date": "2016-11-30 18:27:38 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-wmih-corp-november-30-2016/", "summary": "ETFs with exposure to WMIH Corp. : November 30, 2016" }, { "title": "WMIH CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits", "publication_date": "2016-11-23 21:18:37 +0000", "url": "http://biz.yahoo.com/e/161123/wmih8-k.html", "summary": "WMIH CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits" }, { "title": "WMIH CORP. Financials", "publication_date": "2016-11-11 18:04:16 +0000", "url": "http://finance.yahoo.com/q/is?s=wmih", "summary": "WMIH CORP. Financials" }, { "title": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2016-11-04 20:29:04 +0000", "url": "http://biz.yahoo.com/e/161104/wmih8-k.html", "summary": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "WMIH CORP. Files SEC form 10-Q, Quarterly Report", "publication_date": "2016-11-04 20:17:33 +0000", "url": "http://biz.yahoo.com/e/161104/wmih10-q.html", "summary": "WMIH CORP. Files SEC form 10-Q, Quarterly Report" }, { "title": "ETF’s with exposure to WMIH Corp. : November 1, 2016", "publication_date": "2016-11-01 16:42:49 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-wmih-corp-november-1-2016/", "summary": "ETF’s with exposure to WMIH Corp. : November 1, 2016" }, { "title": "KKR Swings to a Profit, Bolstered by Credit and Energy Gains", "publication_date": "2016-10-25 08:25:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/80krGm1KiqQ/kkr-swings-to-a-profit-bolstered-by-credit-and-energy-gains-20161025-00713", "summary": "KKR Swings to a Profit, Bolstered by Credit and Energy Gains" }, { "title": "Five Cheap Financial Stocks Hedge Funds Love", "publication_date": "2016-10-09 21:19:22 +0000", "url": "http://www.insidermonkey.com/blog/five-cheap-financial-stocks-hedge-funds-love-478185/", "summary": "Five Cheap Financial Stocks Hedge Funds Love" }, { "title": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2016-10-05 20:17:45 +0000", "url": "http://biz.yahoo.com/e/161005/wmih8-k.html", "summary": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "WMIH Corp. breached its 50 day moving average in a Bearish Manner : WMIH-US : September 21, 2016", "publication_date": "2016-09-21 12:21:45 +0000", "url": "http://www.capitalcube.com/blog/index.php/wmih-corp-breached-its-50-day-moving-average-in-a-bearish-manner-wmih-us-september-21-2016/", "summary": "WMIH Corp. breached its 50 day moving average in a Bearish Manner : WMIH-US : September 21, 2016" }, { "title": "LendingClub Taps Thomas Casey as Finance Chief", "publication_date": "2016-09-12 17:25:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/252By9c1CSA/lendingclub-taps-thomas-casey-as-finance-chief-20160912-01126", "summary": "LendingClub Taps Thomas Casey as Finance Chief" }, { "title": "LendingClub Names WaMu Veteran as Finance Chief", "publication_date": "2016-09-12 17:25:00 +0000", "url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hlKm2rLMdv0/lendingclub-names-wamu-veteran-as-finance-chief-20160912-01195", "summary": "LendingClub Names WaMu Veteran as Finance Chief" }, { "title": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2016-09-09 20:18:01 +0000", "url": "http://biz.yahoo.com/e/160909/wmih8-k.html", "summary": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "ETF’s with exposure to WMIH Corp. : September 2, 2016", "publication_date": "2016-09-02 14:42:15 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-wmih-corp-september-2-2016/", "summary": "ETF’s with exposure to WMIH Corp. : September 2, 2016" }, { "title": "Callaway Golf, WMIH Rank Among The 5 Most Popular Micro-Cap Stocks Among Hedge Funds", "publication_date": "2016-08-26 20:49:45 +0000", "url": "http://www.insidermonkey.com/blog/callaway-golf-wmih-rank-among-the-5-most-popular-micro-cap-stocks-among-hedge-funds-470639/", "summary": "Callaway Golf, WMIH Rank Among The 5 Most Popular Micro-Cap Stocks Among Hedge Funds" }, { "title": "ETF’s with exposure to WMIH Corp. : August 15, 2016", "publication_date": "2016-08-15 14:59:09 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-wmih-corp-august-15-2016/", "summary": "ETF’s with exposure to WMIH Corp. : August 15, 2016" }, { "title": "WMIH Corp. :WMIH-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016", "publication_date": "2016-08-12 16:27:01 +0000", "url": "http://www.capitalcube.com/blog/index.php/wmih-corp-wmih-us-earnings-analysis-q2-2016-by-the-numbers-august-12-2016/", "summary": "WMIH Corp. :WMIH-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016" }, { "title": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits", "publication_date": "2016-08-11 20:17:32 +0000", "url": "http://biz.yahoo.com/e/160811/wmih8-k.html", "summary": "WMIH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits" }, { "title": "WMIH CORP. Files SEC form 10-Q, Quarterly Report", "publication_date": "2016-08-05 20:20:52 +0000", "url": "http://biz.yahoo.com/e/160805/wmih10-q.html", "summary": "WMIH CORP. Files SEC form 10-Q, Quarterly Report" }, { "title": "WMIH Corp. breached its 50 day moving average in a Bearish Manner : WMIH-US : July 26, 2016", "publication_date": "2016-07-26 12:18:17 +0000", "url": "http://www.capitalcube.com/blog/index.php/wmih-corp-breached-its-50-day-moving-average-in-a-bearish-manner-wmih-us-july-26-2016/", "summary": "WMIH Corp. breached its 50 day moving average in a Bearish Manner : WMIH-US : July 26, 2016" }, { "title": "WMIH Corp. breached its 50 day moving average in a Bullish Manner : WMIH-US : July 13, 2016", "publication_date": "2016-07-13 13:08:48 +0000", "url": "http://www.capitalcube.com/blog/index.php/wmih-corp-breached-its-50-day-moving-average-in-a-bullish-manner-wmih-us-july-13-2016/", "summary": "WMIH Corp. breached its 50 day moving average in a Bullish Manner : WMIH-US : July 13, 2016" }, { "title": "WMIH Corp. Joins Russell 2000® Index", "publication_date": "2016-06-28 12:00:00 +0000", "url": "http://finance.yahoo.com/news/wmih-corp-joins-russell-2000-120000811.html", "summary": "[PR Newswire] - SEATTLE, June 28, 2016 /PRNewswire/ -- WMIH Corp. (WMIH) (the \"Company\" or \"WMIH\") today announced that it has been added to the Russell 2000® Index. Annual reconstitution of the Russell US indexes captures the 4,000 largest US stocks as of the end of May, ranking them by total market capitalization. The Russell 2000® Index measures the performance of approximately 2,000 of the leading small company stocks in the United States." }, { "title": "WMIH Corp. breached its 50 day moving average in a Bullish Manner : WMIH-US : June 24, 2016", "publication_date": "2016-06-24 12:28:54 +0000", "url": "http://www.capitalcube.com/blog/index.php/wmih-corp-breached-its-50-day-moving-average-in-a-bullish-manner-wmih-us-june-24-2016/", "summary": "WMIH Corp. breached its 50 day moving average in a Bullish Manner : WMIH-US : June 24, 2016" }, { "title": "ETF’s with exposure to WMIH Corp. : June 20, 2016", "publication_date": "2016-06-20 19:28:39 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-wmih-corp-june-20-2016/", "summary": "ETF’s with exposure to WMIH Corp. : June 20, 2016" }, { "title": "WMIH CORP. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders", "publication_date": "2016-06-07 20:03:21 +0000", "url": "http://biz.yahoo.com/e/160607/wmih8-k.html", "summary": "WMIH CORP. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders" }, { "title": "WMIH Corp. breached its 50 day moving average in a Bearish Manner : WMIH-US : June 6, 2016", "publication_date": "2016-06-06 12:25:43 +0000", "url": "http://www.capitalcube.com/blog/index.php/wmih-corp-breached-its-50-day-moving-average-in-a-bearish-manner-wmih-us-june-6-2016/", "summary": "WMIH Corp. breached its 50 day moving average in a Bearish Manner : WMIH-US : June 6, 2016" }, { "title": "Five Cheap Finance Stocks With Big Hedge Fund Support", "publication_date": "2016-05-27 13:45:56 +0000", "url": "http://www.insidermonkey.com/blog/five-cheap-finance-stocks-with-big-hedge-fund-support-455540/", "summary": "Five Cheap Finance Stocks With Big Hedge Fund Support" }, { "title": "WMIH Corp. breached its 50 day moving average in a Bullish Manner : WMIH-US : May 26, 2016", "publication_date": "2016-05-26 12:38:07 +0000", "url": "http://www.capitalcube.com/blog/index.php/wmih-corp-breached-its-50-day-moving-average-in-a-bullish-manner-wmih-us-may-26-2016/", "summary": "WMIH Corp. breached its 50 day moving average in a Bullish Manner : WMIH-US : May 26, 2016" }, { "title": "ETF’s with exposure to WMIH Corp. : May 18, 2016", "publication_date": "2016-05-18 00:46:26 +0000", "url": "http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-wmih-corp-may-18-2016/", "summary": "ETF’s with exposure to WMIH Corp. : May 18, 2016" }, { "title": "WMIH Corp. :WMIH-US: Earnings Analysis: Q1, 2016 By the Numbers", "publication_date": "2016-05-17 17:38:10 +0000", "url": "http://www.capitalcube.com/blog/index.php/wmih-corp-wmih-us-earnings-analysis-q1-2016-by-the-numbers/", "summary": "WMIH Corp. :WMIH-US: Earnings Analysis: Q1, 2016 By the Numbers" }, { "title": "WMIH CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits", "publication_date": "2016-05-16 21:19:04 +0000", "url": "http://biz.yahoo.com/e/160516/wmih8-k.html", "summary": "WMIH CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits" }, { "title": "WMIH Corp. breached its 50 day moving average in a Bullish Manner : WMIH-US : May 16, 2016", "publication_date": "2016-05-16 12:08:06 +0000", "url": "http://www.capitalcube.com/blog/index.php/wmih-corp-breached-its-50-day-moving-average-in-a-bullish-manner-wmih-us-may-16-2016/", "summary": "WMIH Corp. breached its 50 day moving average in a Bullish Manner : WMIH-US : May 16, 2016" }, { "title": "WMIH Corp. To Webcast 2016 Annual Meeting of Stockholders", "publication_date": "2016-05-10 20:05:00 +0000", "url": "http://finance.yahoo.com/news/wmih-corp-webcast-2016-annual-200500788.html", "summary": "[PR Newswire] - SEATTLE, May 10, 2016 /PRNewswire/ -- WMIH Corp. (NASDAQ: WMIH) today announced that it will hold its 2016 Annual Meeting of Stockholders on Wednesday, June 1, 2016 at 11:00 am EDT. The event will be webcast ..." } ], "result_count": 48, "page_size": 250, "current_page": 1, "total_pages": 1, "api_call_credits": 1 }, "chart":[{"values":[ {"x":"1489411800","y":"1.125"},{"x":"1489412100","y":"1.125"},{"x":"1489412400","y":"1.125"},{"x":"1489412700","y":"1.125"},{"x":"1489413000","y":"1.15"},{"x":"1489413300","y":"1.15"},{"x":"1489413600","y":"1.2"},{"x":"1489413900","y":"1.2"},{"x":"1489414200","y":"1.2"},{"x":"1489414500","y":"1.2"},{"x":"1489414800","y":"1.175"},{"x":"1489415100","y":"1.2"},{"x":"1489415400","y":"1.2"},{"x":"1489415700","y":"1.175"},{"x":"1489416000","y":"1.175"},{"x":"1489416300","y":"1.15"},{"x":"1489416600","y":"1.175"},{"x":"1489416900","y":"1.1501000000000001"},{"x":"1489417200","y":"1.175"},{"x":"1489417500","y":"1.15"},{"x":"1489417800","y":"1.175"},{"x":"1489418100","y":"1.175"},{"x":"1489418400","y":"1.175"},{"x":"1489418700","y":"1.175"},{"x":"1489419000","y":"1.175"},{"x":"1489419300","y":"1.175"},{"x":"1489419600","y":"1.15"},{"x":"1489419900","y":"1.175"},{"x":"1489420200","y":"1.175"},{"x":"1489420500","y":"1.15"},{"x":"1489420800","y":"1.175"},{"x":"1489421100","y":"1.175"},{"x":"1489421400","y":"1.175"},{"x":"1489421700","y":"1.175"},{"x":"1489422300","y":"1.175"},{"x":"1489422600","y":"1.175"},{"x":"1489422900","y":"1.15"},{"x":"1489423200","y":"1.15"},{"x":"1489423500","y":"1.175"},{"x":"1489423800","y":"1.175"},{"x":"1489424100","y":"1.175"},{"x":"1489424400","y":"1.175"},{"x":"1489424700","y":"1.175"},{"x":"1489425000","y":"1.15"},{"x":"1489425300","y":"1.15"},{"x":"1489425600","y":"1.175"},{"x":"1489425900","y":"1.15"},{"x":"1489426200","y":"1.15"},{"x":"1489426500","y":"1.2"},{"x":"1489426800","y":"1.175"},{"x":"1489427100","y":"1.175"},{"x":"1489427400","y":"1.15"},{"x":"1489427700","y":"1.2"},{"x":"1489428000","y":"1.175"},{"x":"1489428300","y":"1.175"},{"x":"1489428600","y":"1.15"},{"x":"1489428900","y":"1.175"},{"x":"1489429200","y":"1.175"},{"x":"1489429500","y":"1.175"},{"x":"1489429800","y":"1.175"},{"x":"1489430100","y":"1.175"},{"x":"1489430400","y":"1.175"},{"x":"1489430700","y":"1.125"},{"x":"1489431000","y":"1.125"},{"x":"1489431300","y":"1.125"},{"x":"1489431600","y":"1.125"},{"x":"1489431900","y":"1.1"},{"x":"1489432200","y":"1.1"},{"x":"1489432500","y":"1.125"},{"x":"1489432800","y":"1.15"},{"x":"1489433100","y":"1.125"},{"x":"1489433400","y":"1.15"},{"x":"1489433700","y":"1.125"},{"x":"1489434000","y":"1.15"},{"x":"1489434300","y":"1.125"},{"x":"1489434600","y":"1.125"},{"x":"1489434900","y":"1.15"},{"x":"1489435200","y":"1.15"} ], "color":"#03a9f4"}]}
]
